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Abstract
Background
Local anaesthesia is known to be a safe and effective method for postoperative pain manage-
ment in adults and children. This convenient method is however rarely used in term and 
preterm infants, despite its obvious benefits. This is due to lack of research and experience in 
the area.
The free fraction of local anaesthetics is responsible for both toxicity and efficacy. Alpha-1-ac-
id-glycoprotein (AAGP) has a high affinity for amide local anaesthetics, thus plasma levels 
of AAGP determine the free fraction of LA. This is why this glycoprotein is important when 
determining dosages of LA infusions. There are very few studies concerning AAGP in new-
borns and none in extremely preterm infants. 
Aims  
• To assess the safety and efficacy of local anaesthesia administered by wound catheter after 
major surgery in term- and preterm infants.
• To investigate levels of alpha-1-acid-glycoprotein in new-borns after delivery, and their 
correlation to age and mode of delivery.
Methods
The studies were performed at departments of Neonatology and Paediatric Anaesthesia and 
Intensive care at Karolinska University Hospital. All patients were term and preterm new-
born infants.
In the first two studies blood was obtained postoperatively after major surgery from patients 
with wound catheters for determination of Levobupivacaine (LB) concentrations after in-
termittent (StudyI) or continuous (Study II) infusion with LB: The first study used a sam-
pling protocol of six samples over a 24 hour period and the second study used four samples 
in 72 hours. Pain was assessed using validated pain scales and morphine consumption was 
registered. In Study III levels of AAGP was determined in blood sampled from umbilical 
arteries direct after delivery.
Results/Conclusions
Studies I and II: The studied infusion regimens with LB administered by wound catheters 
was associated with plasma levels of LB well below toxicity. We also noted good wound heal-
ing, low pain scores and reduced need for opioids compared to our normal clinical experi-
ence. Study III:  This study suggest a significant correlation between increasing gestational 
age and increasing levels of AAGP in plasma. AAGP levels in plasma seem to correspond with 
increasing maturity of the new-born infant. Gender and birth weight did not seem to influ-
ence AAGP concentrations in plasma. Infants born vaginally had significantly higher levels of 
AAGP compared to those born with planned caesarean section.
• Local anaesthesia by wound catheter administration in term- and preterm new-born 
infants is a safe method to use.
• Gestational age and mode of delivery should be factors when determining dosage of local 
anaesthetics.
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91 INTRODUCTION
Elsa
101 years ago Elsa was born as the first child to her parents. The lady who deliv-
ered her immediately noticed that Elsa was very small. The lady used the kitchen 
scale and found that Elsa weighed 2,1 kg. Her skin looked very red and shiny. She 
was breathing and screamed with a fragile voice but didn’t have the strength to 
breastfeed, and as the days went by she deteriorated and got more and more 
tired. Elsa´s grandmother tried to feed her with diluted cows milk by spoon. De-
spite the efforts made to feed Elsa she passed away on the fifth day of her short 
life.
Patrick
53 years ago Patrick was born in gestational week 34 weighing 2 kg after a cae-
sarean section due to bleeding and ablation of the placenta. Patrick developed 
difficulties in breathing and deteriorated within the first 24 hours. He was trans-
mitted to another hospital where he was put in a hyperbaric chamber to help his 
condition but it didn’t make his breathing more stabile. He died just two days 
old.
Erik
16 years ago Erik was born in gestational week 34 weighing 2 kg after caesarean 
section due to ablation of the placenta. Erik was directly admitted to the Neona-
tal intensive care unit (NICU) of the hospital. He developed difficulties in breath-
ing and received medical attendance and professional nursing. On the second 
day of his life Erik was already getting better. When he was just one week old he 
could go home with his parents. Today he is a healthy 16 year-old boy and has 
not spent a day in hospital since he left the neonatal ward.
Otto
5 years ago Otto was born in gestational week 25 weighing 700 g. He immedi-
ately contracted acute lung disease due to immaturity and was admitted to the 
NICU were he was given ventilator treatment for one week. At two weeks of age 
he underwent heart and bowel surgery for conditions common for extremely 
preterm babies. Otto is now 5 years old, and still has to visit the hospital from 
time to time. He has short bowel syndrome, and he is often in need of inhalation 
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during the cold season. Otherwise he is doing fine and he had nice results in the 
5 year follow up including psychological tests.
Hugo
6 months ago Hugo was born in gestational week 22 weighing 420 g. Being very 
fragile and not capable of breathing by him self he was immediately put on the 
ventilator and consequently needed full intensive care for several months. Hugo 
was operated on more than 20 times in the bowel and chest during his stay in the 
neonatal unit, and he also lost an arm due to bad circulation. 
Hugo had major bleedings in the brain and developed severe lung disease due 
to his extreme immaturity. He is still on the ventilator and in need of various 
operations to his bowels and on his arm and accordingly in great need for ad-
vanced pain medication.
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2 BACKGROUND
Caring for the woman giving birth is one of the oldest forms of organized medi-
cine. In the ancient world, the focus of the midwife was solely on the safe delivery 
of the mother. However, even in pre-modern days efforts were made to help in-
fants with different postnatal issues such as being small, not holding the tempera-
ture, having difficulties in feeding etc. 
The premature birth and death of Patrick Kennedy, son of U.S. President Jon 
F. Kennedy, is often considered the birth of modern neonatology. In the attempt 
to save the presidential baby s´ life, new ground was broken, uncharted medical 
territory was explored and a new medical discipline came to life.
The stories in the introduction show us that modern neonatology has come 
very far in a short time. We are now able to safe the lives of infants born as early 
as gestational week 22 and weighing as little as 400 g. As thrilling as these medical 
advances may be, one has to remember that this new category of patients invariably 
has a need for advanced intensive care and painful procedures.  As in the example 
above with Otto and Hugo common procedures are tracheal intubation, intrave-
nous and arterial puncture, insertion of central venous catheters and major sur-
gery. Common indications for surgery are persistence of arterio-venous duct and 
nectrotizing enterocolitis (NEC). 
It was only some decades ago that the common belief, even in the profession, 
was that term- and preterm infants did not have the capability of feeling and re-
membering pain. This view of course made any pain treatment of infants su-
perfluous. Research and clinical experience have shown us the opposite. These 
patients are much more vulnerable to pain due to their immature and growing 
nervous system.1-3 Pre-terms are also at great risk of developing both short- and 
long-term complications to pain.
Term and near term infants are also subjected to major surgery due to mal-
formations such as gastrochisis, omfalocele, diaphragmatic hernia, oesophageal 
and duodenal atresia etc.
Postoperative analgesia
Postoperative pain remains one of the main problems both when it comes to pa-
tient satisfaction and delayed discharge from hospital after surgery.4, 5
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There is further more a potential risk of developing persistent postoperative 
pain (PPP) which in turn could lead to chronic pain.6
Opioids are still the base for postoperative analgesia in both adults and chil-
dren. This is despite well-known negative side effects such as constipation, un-
wanted sedation, respiratory depression and withdrawal symptoms. There are 
long-term negative effects such as immune suppression and delayed neurologi-
cal development.5, 7-10 Treatment with opioids makes the patient stay longer on 
the ventilator, thus prolonging the time admitted to hospital. This, in turn, causes 
problems in developing interaction with the parents and increasing costs for so-
ciety. 
Other intravenous drugs such as paracetamol and clonidine are used postop-
eratively alongside opioids as part of a multimodal analgesic regime.11 Non-ste-
roidal anti-inflammatory drugs (NSAID) are not used in new-borns. 
Local Anaesthetics/Levobupivacaine
Local Anaesthetics has been used since 1884 starting with cocaine for eye sur-
gery. Swedish researchers and physicians have a long history of developing and 
using local anaesthetic drugs and regional anaesthetic techniques. 
We know that local anaesthetics and regional anaesthetic methods has good 
effects and are safe in adults and older children4, 12-14, but are still infrequently 
used in neonates. 
Levobupivacaine (LB) is the local anaesthetic of preference in Astrid Lind-
gren Children´ s Hospital due to its favourable low-toxic profile and long duration. 
It is also the local anaesthetic used in the studies of this thesis.15 It is the pure S 
(-) enantiomer of bupivacaine and is seen as a safer alternative than its racemic 
parent. LB is an amino-amide type of local anaesthetic drug with a more pro-
nounced sensory- than motor block.15 The potency of LB is similar to that of bu-
pivacaine, although it has been shown to have longer duration in lower doses.16-18 
It has also been shown that the duration of LB blocks is much longer in peripheral 
and regional blocks than in epidural blocks.19
Mechanism of action
LB as well as other local anaesthetic blocks the generation and conduction of 
nerve impulses. This is accomplished by slowing the propagation of the nerve im-
pulse and by reducing the rate of rise of the action potential.20 The drug binds to 
the intracellular portion of sodium channels and blocks sodium influx into nerve 
cells, thereby preventing depolarization.
Onset of action of LB has been noted to be less than 15 minutes in multiple 
studies.19, 21-25 LB is a long acting local anaesthetic drug with different durations 
in different kinds of blocks.19
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Absorption
The plasma concentration of LB depends on route of administration and dosage. 
The route is important because there is a great difference of vascularity in differ-
ent tissues.15
Metabolism
LB is metabolized by enzymes. CYP3A4 isoform and CYP1A2 isoform is mainly 
responsible for the metabolization to desbutyl-levobupivacaine and 3–hydroxy 
-levobupivacaine, respectively.18 Desbutyl -levobupivacaine is converted to sul-
phate ester conjugates and glucoronic acid.  It is likely that liver dysfunction have 
an effect that could be significant when it comes to elimination of LB (Purdue 
Pharma L.P 1999, Abbott laboratories 1999)
Elimination
Approximately 95% of metabolites of LB are eliminated via the urine (71%) or 
faeces (24%) in 48 hours. (Purdue Pharma L.P 1999, Abbot laboratories 1999) 
Toxicity
 There is always, as for all local anaesthetics a potential risk for LAST (Local An-
aesthesia System Toxicity). LAST presents with diverse symptoms such as cardi-
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tive pain management in both adults29 and children.13, 30 It has been considered 
equally safe and effective, and thus considered to be the first choice of treatment. 
This preferential treatment of EDA has recently been questioned due to a suspect-
ed underestimation of the risks involved as well as an overestimation of its effi-
cacy.4, 31  In the paediatric population there has been reports of catastrophic out-
comes when using epidurals.32, 33 Questions concerning the duration of epidural 
infusions has also been raised for the neonatal population due to uncertainty 
regarding the rate of drug elimination.34 Furthermore, epidurals are seldom used 
in preterm patients due to the obvious difficulty and risk concerning the insertion 
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of the catheter in the neonates narrow epidural space. In our unit sacral analgesia 
in neonates, are considered a both safer and easier alternative to EDAs. In our 
practise, a catheter is not placed in situ and the method is only used for “lower” 
surgery such as inguinal hernia and anal atresia.
Nerve blocks
Different kinds of peripheral nerve blocks are considered a better method than 
intravenous or epidural analgesia and are today more frequently used.35, 36 With 
the introduction of ultrasound these techniques has become very safe and are 
nowadays also used in paediatric anaesthesia.
In small infants such as neonates and preterms however, the method still 
presents some difficulties. The small size of the patient makes it very difficult to 
place the catheter in the right position as well as administering correct dosage of 
the local anaesthetic. There is theoretically also a greater risk for intra-neural or 
intravascular injection of the local anaesthetic.
 Local infiltration analgesia using a mix of local anaesthetics, adrenalin and 
ketorolac is commonly used for postoperative analgesia after knee and hip ar-
throplasty, with or without indwelling catheter. This technique is opioid sparing 
and easier to perform than for instance femoral block but it is not used in paedi-
atric surgery.37
Wound catheter infusions
In the neonatal department at Karolinska hospital we have since a decade used 
wound catheters as the primary analgesic method after surgical closure of the ar-
terio-venous duct in extremely preterm infants. This is mainly due to the fact that 
it is technically very advanced, time consuming and to some extent dangerous to 
insert an epidural catheter in a patient weighing around 700 g and we know that 
high doses of morphine and other opioids effects the preterm negatively both in 
the short and long term.7-9 
The easiest and probably safest way to administer local anaesthesia is under 
direct vision by the surgeon in the wound and also in many cases effective and 
opioid sparing.38 Avoiding neural damage and intravascular injection is impor-
tant and this is more likely to happen if the patient is very small. 
Wound catheter techniques have been shown to be both safe and effective 
with opioid sparing effects in adult postoperative care.39, 40 There are also reports 
not showing an overall positive effect of these techniques.41, 42
The catheters are multi-orifice tubes of different lengths and diameters. These 
are placed in the wound by the surgeon after major surgery (Figure 1). The cath-
eter is placed superficially to the muscle fascia under direct supervision of the 
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surgeon. Local anaesthetics are then administered through the catheter as 
boluses and/or as infusions postoperatively.
Wound catheters has until now been infrequently used in the paediatric pop-
ulation even tough there are studies showing good results including intra- and 
postoperative use following sternotomy, iliac bone grafting and minor to moder-
ate abdominal surgery.43-45
Due to its simplicity and safety, wound catheter infusions might be a perfect 
way to introduce postoperative analgesia treatment with local anaesthesia in neo-
natal patients.
Pain scoring in neonatal patients
There are for obvious reasons great difficulties in assessing pain in the neona-
tal population with the patients not being able to communicate and also being 
neurologically immature. The response to painful procedures is very different in 
an extremely preterm infant compared to a term new born.  For these reasons 
there are no universal approach to neonatal pain assessment.46 Objective mea-
surements such as blood pressure, heart rate, respiratory rate are used alongside 
with validated pain scales. In the studies in this thesis we have used the scales that 
were “clinical standard” on the wards at that time. EDIN (Echelle Douleur Incon-
fort Noveau).47 and ALPS (Astrid Lindgren Pain Scale).48 Both of these scales are 
behavioural markers. Facial expression, body movement, quality of sleep, contact 
with staff and consolability are examples of variables being assessed. Scores are 
given (0-3, 0-2 respectively in the different scales), and when the score reaches a 
certain figure, interaction of some sort must be done to relieve the infants pain. 
Figure 1
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Alpha-1-acid-glycoprotein
Alpha-1-acid-glycoprotein (AAGP) is an acute phase plasma protein consisting of 
41% carbohydrate and 59% protein.49, 50  AAGP is produced by hepatocytes, but 
extra-hepatic production by endothelial cells has been described.49, 51
Two genes located on chromosome 9 (ORM1 and ORM2) have been identi-
fied to encode two types of AAGP.52 The two types of AAGP differs by 22 amino 
acids.
The only established function of AAGP is to act as a carrier of basic and neu-
trally charged lipophilic compounds such as basic drugs (for example local anaes-
thetics).49 AAGP is alongside with albumin and lipoprotein the major drug bind-
ing protein in plasma.
AAGP is produced and released in response to different types of stress such 
as inflammation, trauma or surgery.51, 53 The acute phase reaction causes cyto-
kines, prostaglandine E2 and cyclic adenosine monophosphate (cAMP) to stim-
ulate the production of AAGP. Cancer, malnutrition and inflammatory disease 
such as rheumatism can also affect the production of AAGP.49, 53 The levels of 
AAGP may also vary due to non-pathological factors such as weight, pregnancy, 
age, tobacco smoke etc. 
As mentioned above LA has a high affinity for AAGP thus altering the free 
fraction, which is responsible for both toxicity and efficacy of the drug. It is al-
ready well known that AAGP levels alter due to surgery thus affecting the free 
fraction of the administered anaesthetic. Since AAGP is produced in the liver, the 
function and maturity of the organ also has great bearing on the dosage of local 
anaesthetics.
There are studies showing that new-borns have much lower levels of AAGP 
than adults54  Prior to our studies there were no data on the influence of mode of 
delivery on AAGP levels.
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3 AIMS
This project aimed to improve and gain knowledge of local anaesthesia in term- 
and preterm infants.
1. To investigate if local anaesthesia is a safe and effective method in term and 
preterm infants when used via a wound catheter after major surgery.
2. Whether the plasma concentration of LA in neonates reaches levels linked to 
toxicity using a wound catheter with levobupivacaine.
3. To search for signs of negative effect of wound healing
4. To determine normal values of the plasma glycoprotein alpha-1-acid- 
glycoprotein(AAGP) in term and preterm infants, and look for differences 
due to gestational age, birthweight, gender and mode of delivery in the levels 
of AAGP.
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4  METHODS
The studies were performed according to the declaration of Helsinki and ap-
proved by the Regional Ethical Review Board of Stockholm, Sweden. 
Parental consent was obtained in all cases.
Patient Demographics 
108 new-born infants were included in the studies.
Study I Following Ethics Committee (Dnr: 2008/482-31) approval and written 
parental informed consent, 18 extreme preterm infants scheduled for surgical 
closure of patent ductus arteriosus (PDA) were included into the study. (table 1) 
Median weight was 721g and the infants were born between gestational week 23 
to 27. The studied groups were similar in terms of patient demographics.
Group BII  DII 
Gender (M/F) 6/3 4/5
Gest age at birth (weeks) 24.8 (24.0 - 26.6) 26.0 (24.4 - 29.4)
Age at op (weeks+days) 28.4 (26.0 - 32.0) 29.3 (26.8  -33.3)
Birthweight (g) 700( 564 - 937) 752 (600 - 1189)
Table I  BII= Bolus intermittent infusion, DII= Delayed intermittent infusion
Study II Following Ethics Committee (Dnr: 2007/1462-31) approval and written 
parental consent, 20 new-born infants scheduled for major surgery (thoracic or 
abdominal) were included into the study (table 2 and 3). All patients were less 
than 1 month of age at inclusion. 
Diagnosis Patients
Colonic atresia 1
Congenital diaphragmatic hernia 5
Cyst of the lung 3
Duodenal atresia 3
Duodenal stenosis 1
Malrotation of the Intestine 1
Oesophageal atresia 5
Tracheoesophageal fistula 1   
Table 2 Diagnosis
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Patients  
Sex (M/F) 14/6
Gest. age at birth (weeks+days) median (min-max) 39+6 (36+4-41+5)
Postnatal age at surgery (days) median (min-max) 4 (1 - 30)
Weight (g) median (min-max) 3480 (2870 - 4290)
Table 3 Patient demographics 
Study III Following Ethics committee (Dnr: 2014/64-31/2) approval and written 
parental consent 70 new-born infants were included into study III (table 4).  The 
infants were born between gestational week 27 to 41.
Mode of delivery Vaginal  Elective Acute  
  caesarean  caesarean   
  section section
Number of infants (n) 31 26 13
Gender (M/F) 17/14 16/10 7/6
Gestational age at birth  
(days)  median 273 265 263 
(min-max) (191-295) (222-279) (190-293)
Body weight (g)  
median  3363 3439 2873 
(min-max) (1734-4630) (1234-4790) (1058-4000)
AAGP concentration  
(g  L-1) median  0.189 0.110 0.182 
(IQR) (0.142-0.263) (0.094-0.157) (0.121-0.376)
Table 4 Patient demographics
Anaesthetic methods
Study I The patients were already intubated and mechanically ventilated when 
entering the operation room and had arterial and venous lines in place.  Premed-
ication was never used. All infants received atropine (10 microg kg -1), fentanyl 
(10 microg kg -1) and atracurium (0.5 mg kg -1) followed by general anaesthesia 
maintenance with sevoflurane 1.0-1.5% in oxygen/air.
Additional boluses of fentanyl and atracurium were given as needed during 
the operation. A maintenance infusion of glucose 2.5% was given throughout the 
procedure at an infusion rate of  5-10 ml kg -1  h -1.  If intraoperative hypotension 
occurred bolus injections of albumin (5%) were given in doses of 5-10ml kg -1. 
Hypotension was treated at a reduction of mean arterial pressure with more than 
20% compared to preoperatively.
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Study II No premedication was used. The majority of the patients were 
intubated at the operation room whereas a few were already intubated in the in-
tensive care unit. To facilitate endotracheal intubation all patients received atro-
pine (10-20 microg kg-1), fentanyl (1-2 microg kg-1)  and thiopentone (6-8 mg kg-
1) or propofol (2-3 mg kg -1) followed by succinylcholine (2-3 mg kg -1). General 
Anaesthesia was maintained with sevoflurane 2-4% in oxygen/air. As in study I 
fentanyl and atracurium were given during the operation as needed.
Wound catheter placement 
Study I and II Before closure of the 
wound the surgeon placed a wound 
catheter with multiple wholes at the end 
of it superficial to the fascia of the mus-
cle layers.  The catheters in both stud-
ies were of the same brand (Pain Bust-
er, I-flow corporation, Lake Forest, CA, 
USA) and were placed under direct su-
pervision by the surgeon. An introduc-
er needle was fed subcutaneously from 
the medial angle of the wound to a 
point approximately 2-3 cm away (from 
the medial edge of the incision) and the 
catheter was inserted and placed along-
side the length of the wound. 
The size of the catheter was 19 gauge 
and the length 2.5 or 6.5 cm depending 
on the length of the incision.
After the placement of the wound 
catheter, subcutaneous tissue was closed 
with single sutures and finally the skin 
was closed with intracutaneous sutur-
ing technique.  A transparent dressing 
was put over the wound as shown in 
Figure 3.
The catheters were kept in situ for 
72 hours in both studies, and then gen-
tly removed by simply pulling them out. Figure 3
Figure 2
20
Study II No premedication was used. The majority of the patients were 
intubated at the operation room whereas a few were already intubated in the in-
tensive care unit. To facilitate endotracheal intubation all patients received atro-
pine (10-20 microg kg-1), fentanyl (1-2 microg kg-1)  and thiopentone (6-8 mg kg-
1) or propofol (2-3 mg kg -1) followed by succinylcholine (2-3 mg kg -1). General 
Anaesthesia was maintained with sevoflurane 2-4% in oxygen/air. As in study I 
fentanyl and atracurium were given during the operation as needed.
Wound catheter placement 
Study I and II Before closure of the 
wound the surgeon placed a wound 
catheter with multiple wholes at the end 
of it superficial to the fascia of the mus-
cle layers.  The catheters in both stud-
ies were of the same brand (Pain Bust-
er, I-flow corporation, Lake Forest, CA, 
USA) and were placed under direct su-
pervision by the surgeon. An introduc-
er needle was fed subcutaneously from 
the medial angle of the wound to a 
point approximately 2-3 cm away (from 
the medial edge of the incision) and the 
catheter was inserted and placed along-
side the length of the wound. 
The size of the catheter was 19 gauge 
and the length 2.5 or 6.5 cm depending 
on the length of the incision.
After the placement of the wound 
catheter, subcutaneous tissue was closed 
with single sutures and finally the skin 
was closed with intracutaneous sutur-
ing technique.  A transparent dressing 
was put over the wound as shown in 
Figure 3.
The catheters were kept in situ for 
72 hours in both studies, and then gen-
tly removed by simply pulling them out. Figure 3
Figure 2
20
21
Dosing of levobupivacaine (study I, II)
The catheters (0.08ml) were prefilled either with LB or saline according to the 
protocol of the study.
Study I Directly after the wound catheter was put in place by the surgeon a 
bolus dose was given manually with LB (Chirocaine®) 0.625 mg ml -1 (0.2 mg kg -1 
= 0.32ml kg -1.) in group BII and with saline in group DII.
After the infant had been transported back to the neonatal intensive care unit 
an infusion was started according to study protocol.
Bolus plus early start of an intermittent infusion (BII): The infusion was start-
ed with LB (Chirocaine®) 0.625mg ml -1 (2 mg kg -1 24 h -1) and after 8 hours 
switched to saline (Nacl 9mg/ml). The infusion was then switched every 8 hours 
between LB and saline. 
Delayed start of intermittent infusion (DII): The infusion was started with sa-
line, given by the same rate as LB in the BII group and then changed after 8 hours 
to infusion with LB, then switched every 8 hours as seen in the diagram below.
Study II When the operation was finished and the wound was closed the sur-
geon gave a bolus dose of LB (Chirocaine®) 1.25 mg ml -1, 0.5 mg kg -1 (0.4ml kg -1) 
through the wound catheter. When arriving at the Paediatric Intensive Care unit 
20-30 minutes later a continuous infusion was started with LB (Chirocaine®) 1.25 
mg ml -1, at a rate of 0.2 mg kg -1 h -1 (0.16 ml kg -1 h -1). The intended duration of 
the infusion was 72 hours.
Blood sampling
All blood sampling was coordinated with other blood tests according to clinical 
needs. No extra scin punctures were needed in any of the patients. The 3 % rule 
was used in the smallest patients, meaning that the blood collected during the 
study never exceeded 3% of the blood volume of the patient.
Study I Blood was drawn from already existing indwelling catheters in the 
patients. All samples were drawn from peripheral arterial lines except in one pa-
tient where samples were drawn from a central venous line. Samples of maxi-
mum 0.8 ml were drawn at 10, 13, 16, 19, 22 and 24 hours after the bolus injection 
LB NaCl LB NaCl
0h 8 h 16h 32h
NaCl  LB NaCl LB
0h 8 h 16h 32h
21
Dosing of levobupivacaine (study I, II)
The catheters (0.08ml) were prefilled either with LB or saline according to the 
protocol of the study.
Study I Directly after the wound catheter was put in place by the surgeon a 
bolus dose was given manually with LB (Chirocaine®) 0.625 mg ml -1 (0.2 mg kg -1 
= 0.32ml kg -1.) in group BII and with saline in group DII.
After the infant had been transported back to the neonatal intensive care unit 
an infusion was started according to study protocol.
Bolus plus early start of an intermittent infusion (BII): The infusion was start-
ed with LB (Chirocaine®) 0.625mg ml -1 (2 mg kg -1 24 h -1) and after 8 hours 
switched to saline (Nacl 9mg/ml). The infusion was then switched every 8 hours 
between LB and saline. 
Delayed start of intermittent infusion (DII): The infusion was started with sa-
line, given by the same rate as LB in the BII group and then changed after 8 hours 
to infusion with LB, then switched every 8 hours as seen in the diagram below.
Study II When the operation was finished and the wound was closed the sur-
geon gave a bolus dose of LB (Chirocaine®) 1.25 mg ml -1, 0.5 mg kg -1 (0.4ml kg -1) 
through the wound catheter. When arriving at the Paediatric Intensive Care unit 
20-30 minutes later a continuous infusion was started with LB (Chirocaine®) 1.25 
mg ml -1, at a rate of 0.2 mg kg -1 h -1 (0.16 ml kg -1 h -1). The intended duration of 
the infusion was 72 hours.
Blood sampling
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with either saline (DII) or LB (BII) had been given by the surgeon in the opera-
tion room. Immediately after the blood was drawn from the patients it was cen-
trifuged for 10 minutes at 4000 rotations per minute. The plasma was then pipet-
ted and transferred into a preservative free tube where after it was frozen at -18° C 
until analysis.
Study II Blood was collected from already existing catheters (venous or arte-
rial). Samples of maximum 1.5 ml were drawn at 12, 24, 48 and 72 hours postop-
eratively after the first bolus injection had been given in the operation room. The 
blood was immediately centrifuged for 10 minutes at 3000 rotations per minute 
and plasma was separated and frozen at – 20 ° C until analysis.
Study III Blood was sampled from the umbilical artery immediately after de-
livery. The blood was immediately sent to the laboratory in EDTA tubes were it 
was centrifuged and frozen and subsequently analysed (see under analysis).
Laboratory analysis
All analysis were performed at the Karolinska University Hospital Laborato-
ry, Department of Clinical pharmacology and Division of Clinical Chemistry, 
Stockholm Sweden and performed according to Good Clinical Practice (GLP).
Study I Analysis of total plasma LB were performed using detection by a two-
step liquid-liquid extraction followed by liquid chromatography-mass spectrom-
etry  (LC-MS) with doxepin as internal standard. Range of quantification of the 
method was 0.014-2.900 microg ml -1. Method uncertainty was 10% (coefficient 
of variation). 
Study II  Total LB was analysed as above. In addition free unbound LB was 
analysed in this study with the same method. AAGP (Alpha -1-acid –glycopro-
tein ) was analysed using nephelometry with range for quantification being 0.35 
to 108 g L -1.
Study III  In the laboratory the microcuvettes were centrifuged in 20 ° C for 
10 minutes with the Sigma 1-14K (LABEX instrument AB, Osterode am Harz, 
Germany). Plasma AAGP (orosomucoid) was analysed in EDTA plasma with an 
immunoturbedimetric assay on the Cobas C system (Roche Diagnostics, Germa-
ny). Lower limit of quantification was 0.1g L -1, defined as three standard devia-
tions above the lowest standard. Total coefficient of variation was 5 %.
Pain management and pain scoring (study I,II)
Validated pain scales for neonates were used in the studies, EDIN (Echelle Doleur 
Inconfort Noveau) and ALPS (Astrid Lindgren Pain Scale).
Study I  An infusion with morfin at the rate of 10 microg kg h -1 was started 
when the patients arrived at the NICU postoperatively. Pain was assessed every 
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hour by an intensive care nurse using the EDIN pain scale. Additional assess-
ments were made as needed if the patient seemed to be in pain or if for example 
X ray or suctioning of the trachea was performed. According to study protocol, a 
pain score of 3-5 was set as a target range with min score being 0 and max 15. A 
score below the target range e.g. <3 for six consecutive hours resulted in a reduc-
tion of the morphine infusion rate by 2.5 microg kg -1 h -1.  A pain score above the 
target range resulted in administration of recue analgesia (fentanyl 1 microg kg 
-1). If the pain did not subside after the fentanyl dose the morphine infusion rate 
were increased by 2.5 microg kg -1 h -1. 
Study II  Pain was assesses due to PICU protocol every 6th hour using the val-
idated Astrid Lindgren Pain Scale (ALPS). The study patients were treated with 
the established pain medication protocol for the unit. This includes supplementa-
tion of regional anaesthesia with paracetamol (iv) in the doses of 15-20 mg kg -1 
three or four doses per 24 hour and Clonidine 1 microg kg -1 three to four doses 
per 24 hours or as an infusion 5 to 8 microg kg -1 24 h -1. Opioids were given as 
needed for example at high pain scores. All patients were assessed and treated in-
dividually.
Signs of local anaesthesia toxicity
Signs and symptoms of LAST were carefully monitored for. All patients had ECG 
electrodes to detect arrhythmias and nursing staff was specifically instructed to 
note any signs of focal or generalized seizures.
Wound healing
During the study period all patients were examined on a daily basis and before 
discharge from the hospital by the surgeon with focus on wound healing. Any 
signs of leakage or infection were noted by the surgeon and by the nursing staff. 
Normal wound healing was defined as a scar, free from signs of infection or in-
flammation at 10 days postoperatively.
Statistics
Study I  Mann- Whitney U -test was used when calculating differences in terms 
of plasma concentrations of LB between the two groups BII and DII . Fisher´ s ex-
act test was used when comparing classified data from two independent popu-
lations. Plasma concentration data were always expressed as median values and 
range (min-max) as were pain scores and morphine consumption data.
Randomization and blinding procedures: The randomization was performed 
by the hospital pharmacy. The patients were randomized into one out of two 
groups BII and DII. The randomization was performed in blocks of 10 patients. 
All randomization codes were derived from computer –generated numbers and 
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allocated using the sealed opaque envelopes techniques. The pharmacy then pro-
vided syringes that were labelled with a patient number and in which order they 
were to be given to the study patient. Every second syringe contained LB or NaCl 
9mg/ml. The nurse caring for the patient changed the syringe according to the 
protocol every 8 hour. 
Study II Plasma concentration data were expressed as median values and 
range (min /max). Pain scores were also presented as median values. The 95% 
confidence intervals were calculated as stated by Ott and Mendenhall. 
Study III  Data of AAG levels were all expressed as median values and in-
terquartile range. Kruskal-Wallis test (non parametric ANOVA) was used when 
comparing levels of AAGP in infants born with different mode of delivery. Spear-
man correlation test was used when showing the correlation between levels of 
AAGP and gestational age. 
Statistics used in the studies were evaluated with Graph Pad Instat 3.10.
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5 RESULTS
Study I  As described in “Methods” there were two groups, BII and DII with 9 pa-
tients included in each group. One patient from each group was excluded from 
the pharmaco-dynamic part of the study due to violation of the morphine infu-
sion protocol. 
Study II  One patient was excluded due to problems with drawing blood. In three 
of the patients single samples were missing, these patients remained in the study.
Study III  Six subjects were excluded due to missing values from the laboratory.
Plasma concentrations of Levobupivacaine (Study I) 
The plasma concentrations of LB were different in the two studied groups. Figure 
4 Plasma concentrations were higher in the BII group during the 10 to 16 hour 
postoperative period.  16-24 hours postoperatively the concentrations in the two 
groups converged.  Maximum plasma concentration of LB in the BII group was 
1.682 microg ml-1 as opposed to 0.549 microg ml-1 in the DII group. Median plas-
ma concentrations of LB at 24 hours were 0.342 microg ml -1 in the BII group and 
0.106 microg ml-1 in the DII group. There was a notable difference in LB plasma 
concentrations between the groups although not statistical significant (p=0.0653).
 
Figure 4
Plasma concentrations of 
levobupicacaine during 
infusion periods 2 and 3.
• = Concentrations in 
Group BII;  
o = Concentrations in 
Group DII 
During the infusion period 
1(0-8h) patients in Group 
BII were treated with LB 
and patients in Group DII 
were treated with saline. 
No sampling data were 
obtained during this 
period. 
During the infusion period 
2 (8-16h) patients in Group 
BII were treated with saline 
and patients in Group DII were treated with LB. Sampling times: 10, 13 and 16h.
During the infusion period 3 (16-24h) patients in Group BII were treated with LB and patients in 
Group DII were treated with saline. Sampling times: 19, 22 and 24h.
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Plasma concentrations of Levobupivacaine (Study II)
Total plasma concentrations
The maximum total plasma concentration of LB in the study was 3.15 microg ml -1. 
Individual data for the patients are shown in Figure 5. Median total plasma con-
centrations of LB were 0.80 (0.17-1.92), 1.52 (0.06-2.05), 1.37 (0.14-3.15) and 1.30 
(0.08-2.68) microg ml -1 at 12, 24, 48 and 72 hours respectively after the bolus in-
jection. LB concentrations tended to increase during the first 48 hours followed 
by a slight decrease.
 
Figure 5 Total plasma concentrations of LB during the study period.
Unbound plasma concentrations
The maximum unbound plasma concentration of LB in this study was 0.210 mi-
crog ml -1. Individual data for the patients are shown in Figure 6. Median un-
bound plasma concentrations of LB were 0.014 (0.02-0.05), 0.026 (0-0.059), 0.027 
(0-0.208) and 0.017 (0-0.084) microg ml -1 at 12, 24, 48 and 72 hours respectively. 
This shows us that opposed to the total plasma concentrations the unbound frac-
tion seems to be more stable over the entire 72 hour period.
 
Figure 6 Unbound plasma concentrations of LB during the study period.
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Figure 8 AAGP concentrations in relation to mode of delivery
Plasma concentrations of Alpha-1-acid-glycoprotein (Study II)
Data for the individual patients are shown in Figure 7. AAGP was analysed pre-
operatively and 72 hours postoperatively. In all but four patients the concentra-
tions increased, but no correlation was seen between the AAG concentrations and 
the unbound fraction of LB in this material. 
 
Figure 7 AAGP concentrations preoperatively and 72 hours postoperatively  
 respectively.
Plasma concentrations of Alpha-1-acid-glycoprotein (Study III)
Median plasma concentration of AAGP in the subjects was 0.158g L-1 (range 
0.029-0.950 g L-1). 
Median plasma concentrations of AAGP were 0.148 g L-1 and 0.160 g L-1 in 
male and female new-borns respectively (p=ns).
No correlations were found between AAGP concentrations and birth weight 
(rs=0.18; p=0.162).
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A significant difference in AAGP concentrations were seen when comparing 
infants born vaginally with those delivered with planned caesarean section. Con-
centrations of AAGP were much higher in the vaginally born group. Median plas-
ma concentrations of AAGP were 0.115 g L  (range 0.070-0.210 g L -1) and 0.189 g 
L -1 (range 0.100-0.780 g L-1) in infants delivered with planned caesarean section 
and vaginally respectively (p=0.0003). Figure 8
 The concentrations of AAGP also increased significantly with gestational age 
of the subjects, p=0.011 in the group born vaginally. Figure 9
Figure 9 AAGP concentrations in relation to gestational age.
Pain assessment and treatment
Study I  Pain scores were extremely low in the two groups BII (Bolus group) and 
DII (Delayed infusion group). Median EDIN scores were 0 and 1 in the BII and 
DII groups respectively. (p= ns) Numbers of patients in need for rescue analgesia 
(fentanyl) were significantly higher in the DII group: n = 7 as compared to n= 2 
in the BII group (p=0.041). There was no significant difference in morphine con-
sumption between the groups. 
Study II  Pain scores were low in all of the patients during the 72 hour post-
operative period. 
Hours (postop)                          12 24 48 72            
ALPS score (median)  2  1  0  1
The amount of opioids administered during the first 72 hours postoperatively 
ranged from 0 to 1.40 mg kg -1. Three of the patients did not need opioids at all.
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Wound healing
In Study I, a minimal leakage was noted under the transparent dressing in 8 pa-
tients. In all but one patient the wound had healed as expected 10 days postopera-
tively. In one patient there was signs of wound infection and also a positive cul-
ture for staphylococcus and enterococcus on day 15 after surgery.
Study II  Seven infants out of the 20 included (35%; 95% CI 15.4 to 59.3) had 
a mild erythema around the wound that was noted during the time of infusion 
with LB.  A leakage was noted at the edges of the wound or at the catheter inser-
tion site in five patients. In one of those patients, this leakage was excessive and 
the infusion was stopped prematurely at 68 hours. In 18 patients (out of 20) the 
wound had healed 10 days after surgery. One patient had a wound infection with 
staphylococcus aureus that was successfully treated, and one patient had a local 
reaction around the wound due to a protruding suture.
Signs or symptoms of Local Anaesthesia Toxicity (LAST)
No signs of arrhythmias or seizures were noted in any of the patients in Study I 
and II.
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6 DISCUSSION
Recent medical advance have made it possible to rescue extremely preterm in-
fants to life.56-62 These patients are invariably in need of major surgery and ad-
vanced intensive care.63 Postoperative analgesia is for many reasons of utmost im-
portance in this very vulnerable patient category. Both the stress of being in pain 
and the side effects from drugs given to treat pain can in many ways be harmful 
to the immature patient. 
When it comes to postoperative analgesia in term- and preterm new-borns, 
paracetamol,64 clonidine11 and opioids are still used in high doses. Opioid side 
effects such as respiratory depression and reduced bowel motility are everyday 
problems in neonatal wards of today leading to prolonged ventilator treatment 
and increased risk of BPD. Nutritional problems and depressing effects on the im-
mune system are other examples of opioid adverse effects in the neonatal popula-
tion.1-3, 7-9, 65, 66
Since many years, local anaesthetic techniques have been routine in adults 
due to its effectiveness and safety.13, 29, 67  The introduction of LA has lowered the 
need for systemic opioids which in turn has led to lesser side effects, decreased 
costs and shorter hospital stays.4
The aim with this thesis was to look further into pain treatment postopera-
tively in neonatal patients with focus on the use of local anaesthesia.
When determining the best way to administer local anaesthesia in neonates 
there are several aspects to consider such as safety, efficacy, accessibility and costs.
Epidurals and perineural techniques has been mentioned in the background 
part of this thesis and does not seem to be the “perfect” method in this patient cat-
egory due to technical difficulties and risks for side effects.
Wound catheters have been used in adults with both convincing,4, 39 and less 
convincing results.41 On the other hand the methods seems to have many of the 
characteristics that we are looking for, and there are reasons to believe that wound 
catheter techniques could have better possibilities to work in neonates:  
√ Tissues easier to penetrate due to less subcutaneous fat and thinner tissue  
layers.
√ Smaller incisions giving possibility for the local anaesthetic to penetrate  
better vertically. 
√ Easy as well as safe to put into place. 
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Our hypothesis was that wound catheters could be a safe and effective alter-
native to epidurals in this patient category.
AAGP is manly responsible for binding amide local anaesthetics. We were 
therefore interested in looking further into AAGP concentrations in new-borns 
and how it correlate to different factors such as gestational age, mode of delivery, 
gender and birth-weight. This knowledge can be useful when determining a safe 
dosage of local anaesthetics in new-borns.49, 50
Main findings
In the two first studies of the thesis, we found plasma concentrations (both total 
and free) of LB to be far from potential toxic levels. Furthermore, we could not see 
any signs of LAST such as seizures or arrhythmias. 
The main findings in study III was that AAGP plasma concentrations in new-
borns are influenced by gestational age, a fact that to some extent was already 
known,54, 68 we also found that the concentrations alters significantly with mode 
of delivery. 
Furthermore, the study showed that infants delivered by planned caesare-
an section had significantly lower levels of AAGP than those delivered vaginally. 
These are new findings, and we believe they can contribute toward developing 
safe dosages of local anaesthetics in new-born infants. Other new findings were 
that we could not detect any differences in AAGP concentrations related to gen-
der or birth weight.
The result from our Study III not only differs from former studies but also 
contributes with new information. We included as many as 70 new-borns in our 
study, this is a large cohort compared with former studies.54, 67 Earlier studies had 
shown that AAGP concentrations in new-borns were 50% of adult levels.68  Our 
study shows figures around only 20% of adult levels. In comparison with ear-
lier studies our study protocol gives more accurate values for AAGP concentra-
tions. We obtained blood samples directly after delivery from the umbilical ar-
tery, whereas previous studies have obtained samples at different times and from 
different sites. 
Pharmacokinetics 
In Study I there was a tendency of difference between the groups although not 
significant. The bolus and early infusion group (BII) showed higher median con-
centrations of LB. An interesting finding was that the maximum concentration 
of LB in the BII group was three times as high as in the delayed infusion group 69. 
The median LB concentration in the BII group was expected to be higher espe-
cially during the first period, but the maximum concentration being so much 
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higher was somewhat unexpected. In conclusion, both infusion regimens created 
concentrations well below toxic levels but in the BII group the levels were closer 
to toxicity.  
Both total and free concentrations of LB were measured in Study II giving us 
a nice complement to our first study. The concentrations in this study were found 
to be far below toxicity levels, a finding in line with Study I. Median LB concen-
trations after 24-hours of infusion were, as expected, much higher in Study II 
compared to Study I. This is due to the fact that there was a continuous infusion 
of LB, with no periods of saline infusion.   
The free median concentration of LB at 24 hours in Study II was remarkably 
low. It was also constant during the whole study period as opposed to the total 
concentration, which rose from 12 to 48 hours. We have hypothesized that this 
could be due to a rise in AAGP, but we could not show that in this study.
In the light of these results we find LB infusions via wound catheters given 
postoperatively in the used doses and manner is a safe method of analgesia in 
these patients. 
Postoperative analgesia and pain scoring
Objective measurement of pain is very difficult in any patient category.70, 71 In 
new-borns, who are not able to communicate and have a different pain response 
pattern compared to older patients, pain scoring is even more challenging.72-77 
In both studies we could notice less consumption of morphine compared to 
what usually is the case in similar situations without wound catheter analgesia. 
However, we could not make any significant conclusions, mainly due to the study 
setup (few patients, no control group). 
When comparing the two studies, one can see a big difference in morphine 
consumption with much less need for additional opioids in Study II (performed 
at the PICU). This is surprising, since the protocol of study II did not include a 
morphine infusion. Study II was performed in the PICU, where patients from 
this category normally have an epidural catheter postoperatively. The subjects of 
Study I were patients from the NICU, where EDAs are never administered. This 
difference in pain management routines is a possible cause for the difference in 
morphine consumption between the studies. Another reason could be that it is 
harder to assess pain in extremely preterm than in term infants making the staff 
more prone to give extra opioids. 
Wound healing and potential adverse effects  
of wound catheters
When using wound catheters there are for obvious reasons concerns about whether 
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 healing is affected. Another potential adverse effect is infection. 
These questions have been addressed in adults, and there are no convincing 
evidence to support increased risk of infection or delayed wound healing.78-80 
However, studies concerning wound healing are few and none of those include 
long-term follow up of wound healing.81 There are multiple in vitro and animal 
studies that suggest that wound catheter analgesia has adverse effects on wound 
healing, especially at the first two stages (inflammatory and granulation) of heal-
ing. On the other hand there are also studies suggesting that local anaesthetics 
possesses both bactericidal and bacteriostatic effects.82
Our study differs from older studies mainly because of its primary focus on 
wound healing. We inspected the wounds on a daily basis, as well as before dis-
charge. We also had a time limit of ten days for expected wound healing. Only 
two patients (one in each study) had positive wound cultures and delayed healing. 
One patient had a local reaction due to a protruding suture. 
In our studies we saw a mild erythema in several of the patients, which disap-
peared shortly after catheter removal. This could be due to vasodilation as a part 
of an inflammatory response.
In contrast to what is seen in adult patients, we had some problems with leak-
age from either the wounds or from the catheter insertion sites. This is probably 
due to the very small incision site, and also to the greater risk of catheter disloca-
tion compared to larger patients. 
According to our clinical experience and to the findings of these studies, local 
analgesia by wound catheter does not affect wound healing, nor does it increase 
the risk of infection. We have not been able to make any statistically significant 
conclusions since there was no control group in the study, and since the cohort 
was too small.
Implications of AAGP concentrations for dosage  
of local anaesthetics in new-borns
The current routine for paediatric administration of LA includes dose reduction 
when given to neonatal patients compared to older children, and this practice is 
supported by our findings. Further reduction of the dose from 36 to 27 gestation-
al weeks of age seems however unnecessary, since the normal levels of AAGP are 
reasonably stable in this age group. Our study also suggests that infants can pro-
duce AAGP as a response to stress (vaginal delivery). The highly significant find-
ing that AAGP levels are higher in new-borns delivered vaginally compared to 
by caesarean section suggests that giving slightly higher doses of LA in the first 
postnatal period to the vaginally delivered infants might be a prudent course of 
action.
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Future perspectives 
Wound catheter infusion with local anaesthetics
In order to answer the question whether wound catheter infusions with local an-
aesthetics can replace epidural analgesia and intravenous opioids as the new “gold 
standard” after major surgery in neonates, there are several actions that need to 
be taken:
√ Clinical trials comparing wound catheter analgesia with epidural analgesia 
with respect to both safety and efficacy. Theses trials should also include long-
term follow- up of wound healing. 
√ Refining the method by developing new, softer in-wound catheters.
√ A general discussion regarding whether amide local anaesthetics should be 
the first choice in these patient categories is needed. Chlorprocaine, an ester 
local anaesthetic agent, rapidly metabolized by plasma esterases could be an 
interesting alternative in the neonatal group.83 
√ Further studies of the use of adjuvants to the infused local anaethetic. Cloni-
dine is a highly relevant option, and is already used to some extent.84
Alpha-1-acid-glycoprotein
There are still many questions to be answered when it comes to AAGP and new-
borns.
√ How does normal levels change during the first days and weeks of life? 
√ Can term- and preterm infants respond to surgical trauma by producing 
higher concentrations of AAGP as seen in adults.
Our group will contribute with more studies in both of these fields. Hopefully 
we will soon be closer to introducing local anaesthesia for use in a larger number 
of indications, even in the most immature population, the extremely preterm in-
fants.
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7 CONCLUSIONS
1. Levobupivacaine used via a wound catheter after major surgery in term and 
preterm infants is a safe method. No adverse effects where noted in our  
studies.  Local anaesthesia as used in our studies shows a favorabel profile 
when it comes to effectiveness and good analgesia. Morphine consumption 
tended to be low and pain scores were also in the low range.
2. The plasma concentrations of levobupivacaine in both studies were well  
below the thought toxic threashold as measured in adults and animal studies, 
and the unbound fraction was especially low.  No signs or symptoms of local 
anaesthesia toxicity (LAST) were noted.
3. We could not detect any negative effect on wound healing compared to our 
normal clinical experience. 
4. A correlation between gestational age and AAGP levels were 
found with increasingly higher levels in the more mature infants.                                                       
Significantly higher levels of AAGP were noted in infants born vaginally  
compared to those born with planned caesarean section. No differences were 
detected in AAGP concentrations in correlation to gender and birthweight.
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What is already known
• Local anesthetics administered by wound catheter are safe and effective in adults and older children.
What this article adds
• Our study shows that extremely preterm infants can benefit from local anesthetic infusions via wound catheters
postoperatively.
Implications for translation
• Wound catheters with levobupivacaine infusion can be safe and effective in extremely preterm infants as postop-
erative analgesia. Regional techniques such as local anesthesia infusion via wound catheters can reduce the need
for opioids and be a safe and easy alternative to epidurals in this vulnerable patient category.
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Summary
Background: Administration of local anesthetics by a surgically placed
wound catheter has recently been shown to reduce the need for postoperative
morphine administration in extremely preterm infants undergoing ductus
ligation. The primary aim of this randomized safety study was to define the
plasma levels of levobupivacaine (LB) following two different intermittent
infusion regimens.
Methods: Eighteen preterm infants 23–27 gestational weeks, median birth-
weight 721 g scheduled for ductus ligation were included in the study. All
patients were anesthetized according to a standardized protocol based on
high-dose fentanyl (25–50 lgkg1). Before skin closure, a subcutaneous
catheter was inserted into the wound. The patients were randomized to
receive one of the two intermittent infusion regimens: Group BII: Initial
bolus plus early start of the intermittent infusion or Group DII: No bolus
plus delayed start (8 h) of the intermittent infusion. Blood samples for
determination of LB plasma concentrations were obtained on six occasions
during the 24-h postoperative observation period, as well as hourly postop-
erative pain assessments using the Echelle Douleur Inconfort Noveau
(EDIN) pain scale.
Results: Plasma concentrations of LB ranged from 0.094 to 1.682 lgml1
and 0 to 0.549 lgml1 in group BII and DII, respectively. Both regimens
were associated with low postoperative EDIN pain scores (24 h median of 0
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and 1 in group BII and DII, respectively). No signs of systemic local anes-
thetic toxicity were noted.
Conclusions: The two studied intermittent infusion regimens were associated
with plasma levels below potentially toxic levels and were both associated
with adequate postoperative pain scores.
Introduction
Continuous thoracic epidural or paravertebral block-
ade are recommended options for postoperative anal-
gesia following posterolateral thoracotomy in adults
(1) and these techniques are also useful and safe in
children (2–4). Despite isolated case reports regarding
the successful use of such advanced regional tech-
niques in preterm infants, it appears in our opinion
difficult to implement the widespread use of these
modalities in extremely preterm infants. Thus, other
effective regional anesthesia alternatives would be
welcome for these patients when undergoing surgical
ductus ligation.
An adult meta-analysis has found that the use of
wound catheter techniques is surprisingly effective fol-
lowing thoracic and abdominal procedures (5) and suc-
cessful use of wound catheter techniques has also
recently been reported in children following sternotomy,
iliac bone grafting, and minor–moderate abdominal
surgery (6–8).
We have for several years used wound catheters as
the primary analgesic technique following ductus liga-
tion in extremely preterm infants and noted a more
than 50% reduction in morphine consumption (9).
However, during our development of this technique,
we have experienced that intermittent bolus injections
frequently are associated with wound leakage of the
local anesthetic and that continuous infusions occa-
sionally result in plasma levels close to what may
cause systemic toxicity. Thus, an intermittent infusion
strategy has emerged as the best current alternative.
The primary aim of the study was to determine the
plasma levels of levobupivacaine (LB) associated with
two alternative intermittent infusion techniques and
thereby assess if they are associated with a reasonable
margin of safety to toxic levels for long-acting local
anesthetics. Secondary outcome parameters were pain
scores, morphine consumption, need for rescue fentanyl
administration, and wound healing without the inten-
tion of proving one strategy being superior to the other.
Methods
Following Ethics Committee (Dnr: 2008/482-31)
approval and written parental informed consent, 18
preterm infants scheduled for surgical closure of a
patent ductus arteriosus (PDA) were enrolled in the
study (Table 1 patient population). The study has
been performed according to the Declaration of
Helsinki. Exclusion criteria were body weight <500 g
at the time of surgery (due to limitation of total
blood sampling volume), any previous adverse reac-
tion to the administration of local anesthetics, lack of
consent or participation in any other clinical research
study.
General anesthesia protocol
All patients were mechanically ventilated with ade-
quate arterial and venous lines in place. Before trans-
fer from the incubator to the operating table, the
infant received intravenous administration of atropine
(10 lgkg1), fentanyl (10 lgkg1), and atracurium
(0.5 mgkg1).
The patients were ventilated in pressure control mode
(Dr€ager Primus; Dr€ager Company, L€ubeck, Germany)
and anesthesia maintained by sevoflurane 1.0–1.5% in
oxygen/air. During surgery, hand ventilation was used
intermittently as needed. An additional bolus of fentanyl
(15 lgkg1) and atracurium (0.25 mgkg1) was given
before the start of surgery. Additional fentanyl boluses
were administered as needed (increase in heart rate or
blood pressure by >20% compared to preincision), up to
a maximum total dose of 50 lgkg1. A maintenance
infusion of 2.5% glucose (Buffered Glucose 2.5%; B
Braun, Melsungen, Germany) was given throughout
the procedure at an infusion rate of 5–10 mlkg1h1.
Intraoperative hypotension (reduction of >20% com-
pared to preincision) was treated by bolus injections of
5–10 mlkg1 of albumin 5%.
Table 1 Patient population
Group BII DII
Sex (M/F) 6/3 4/5
Gest age at birth
(weeks + days)
24 + 6 (24 + 0–26 + 4) 26 + 0 (24 + 3–29 + 3)
Age at op
(weeks + days)
28 + 3 (26 + 0–32 + 0) 29 + 2 (26 + 6–33 + 2)
Weight at birth (g) 700 (564–937) 752 (600–1189)
Weight at op (g) 887 (642–1185) 840 (668–1650)
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Wound catheter placement
Following closure of the muscle layers, a specially
designed wound catheter (19G Pain Buster, length
2.5 cm; I-Flow corporation, Lake Forest, CA, USA)
was placed under direct vision by the surgeon before
final closure of the wound. An introducer needle with
sheath was fed subcutaneously from the medial angle of
the wound to a point approximately 2–3 cm away (from
the medial edge of the incision), and the catheter was
inserted and placed along the length of the wound. The
wound was then closed with continuous subcutaneous
sutures and a continuous intracutaneous suture. Finally,
the wound was covered with a transparent dressing
(Figure 1). The wound catheters were scheduled to be
removed 72 h postoperatively.
Bolus plus early start of an intermittent infusion (BII)
Following the application of the transparent dressing
and after prefilling the catheter (0.08 ml), a manual
bolus injection of LB was performed by the surgeon
(0.625 mgml1, 0.2 mgkg1 = 0.32 mlkg1). As soon
as the infant had been transferred back to a normal and
stable Neonatal intensive care unit (NICU) situation, a
continuous infusion through the wound catheter was
started. The infusion was switched every 8 h between
LB and saline (for blinding purposes, please see Study
design, statistics, and randomization below), starting
with an 8-h infusion period of LB 0.625 mgml1,
2.0 mgkg124 h1 = 3.2 mlkg124 h1.
This regimen was chosen based on the notion that
immediate bolus administration of LB followed by
active infusion for 8 h may result in optimization of the
effect of this treatment modality.
Delayed start of intermittent infusion (DII)
In this group, the bolus injection was performed with
saline, later followed by continuous infusion in the
NICU in a similar fashion as for group BII. However, in
the DII group, the infants first received an 8-h period of
saline infusion. Thus, LB infusion was first started
approximately 8 h after the end of the operation in this
patient group.
This infusion strategy was based on the notion that the
infants would have adequate postoperative analgesia
from the intraoperative fentanyl load (25–50 lgkg1)
for the first 8–10 postoperative hours because fentanyl
has a prolonged half-life in preterm infants (10). Thus, to
provide additional analgesia by local anesthetics during
this time period may be redundant and might potentially
only result in unnecessary high plasma levels of LB.
Blood sampling
Blood samples were collected at 10, 13, 16, 19, 22, and
24 h after the first bolus (LB or saline) was given in the
operating room. The dead-space of the tubings and the
connectors were adequately cleared before the LB sam-
ples were taken. All samples were arterial except in one
patient where the samples were taken from a central
venous line. The maximum volume of blood collected
at each time was 0.8 ml. All samples were immediately
centrifuged for 10 min at 4042 g. The plasma was then
carefully pipetted and transferred to a preservative-free
plastic tube and frozen at 18°C until analysis.
Levobupivacaine analysis
Quantification of total plasma LB was performed at the
Department of Clinical Pharmacology, Karolinska Uni-
versity Hospital, Stockholm, Sweden, according to
Good Laboratory Practice (GLP). The detection
method is based on sample preparation by a two-
step liquid–liquid extraction followed by separation and
detection by liquid chromatography–mass spectrometry
(LC-MS) using doxepin as internal standard. Quantifi-
cation range of the method was 0.014–2.900 lgml1.
Method uncertainty was <10% (Coefficient of
Variation).
Morphine infusions
Established clinical practice at our hospital has previ-
ously been to start a postoperative morphine infusionFigure 1 External catheter fixation and dressing.
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when the patient returns back to the NICU. The
standard infusion rate is set to 15 lg�kg�1�h�1 to pre-
vent postoperative pain and to allow comfortable
NICU care, including mechanical ventilation. How-
ever, for study purposes, we decided to instead start
the postoperative morphine infusion at a reduced rate
(10 lg�kg�1�h�1) to allow crude evaluation of the
analgesic efficacy of the two infusion regimens (see
below).
Postoperative pain scoring
The Echelle Douleur Inconfort Noveau (EDIN) pain
score instrument is a validated pain score for use in pre-
term infants (11) and represents standard of care in our
NICU. Assessment of pain was performed hourly and
additional assessments were performed as needed in
between the hourly recordings.
A pain score of 3–5 was set as the target range (min
score: 0; max score: 15). A score below the target zone
for six consecutive hours resulted in a reduction of the
morphine infusion rate by 2.5 lg�kg�1�h�1.
A pain score above the target range resulted in admin-
istration of rescue analgesia (see below). If not corrected
by a single dose of rescue analgesia, the morphine infu-
sion rate was increased by 2.5 lg�kg�1�h�1.
Rescue analgesia
In case of pain score >5, the infant received an intrave-
nous dose of fentanyl (1 lg�kg�1).
Signs of systemic local anesthetic toxicity
The nursing staff was specifically instructed to note any
signs of ventricular cardiac arrhythmia or focal/general-
ized seizures.
Wound healing
The wound was inspected daily, and signs of leakage
(presence of visible clear liquid under the transparent
dressing) and infection were noted. Normal wound heal-
ing was defined as a scar free from signs of infection or
inflammation at 10 days postoperatively.
Study design, statistics, and randomization
Study design
Based on our previous data showing a substantial and
clinically relevant morphine sparing effect of the wound
catheter technique (>50% reduction of postoperative
morphine administration) (9), it was not considered ethi-
cal to include a placebo group to the study design. For
rationale regarding the chosen intermittent infusion reg-
imens, please see Discussion section.
Power calculation
As the primary aim of the present study was to deter-
mine the 24-h plasma concentration profile of LB associ-
ated with two different intermittent infusion regimens,
no power calculation was performed with regard to the
primary aim of the study.
Statistical methods
Mann–Whitney U-test was used when calculating differ-
ences between the two groups in terms of plasma con-
centrations. Classified data from two independent
populations were compared by Fisher0s exact test.
Randomization procedure
The patients were randomized into two groups, BII and
DII. The randomization was performed in blocks of 10
patients. The randomization codes were derived from
computer-generated numbers and allocated using the
sealed opaque envelopes technique.
Blinding procedures
To allow proper blinding, the study randomization was
performed by the hospital pharmacy. The pharmacy
provided syringes labeled with the patient number and
in which order they were to be given with every second
syringe containing either LB or normal saline. Every
8 h, the syringes were then switched according to the
study protocol.
Results
In total, 18 preterm infants were enrolled and random-
ized: Group BII: n = 9 and group DII: n = 9. Two
patients were excluded from the postoperative analgesia
analysis: One patient from group DII was excluded due
to an intraoperative surgical rift of the aorta, subse-
quently resulting in an unusual and complicated postop-
erative course. One patient in the BII group was
excluded from the analgesia analysis due to a protocol
violation with regard to the initial postoperative mor-
phine infusion rate (Figure 3).
Levobupivacaine plasma concentrations
The total amount of LB administered during the first
24 h postoperatively was 1.963 mg�kg�1 in Group BII
and 0.664 mg�kg�1 in Group DII.
As expected, the two infusion regimens were associ-
ated with different plasma concentration profiles, with
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standard infusion rate is set to 15 lg�kg�1�h�1 to pre-
vent postoperative pain and to allow comfortable
NICU care, including mechanical ventilation. How-
ever, for study purposes, we decided to instead start
the postoperative morphine infusion at a reduced rate
(10 lg�kg�1�h�1) to allow crude evaluation of the
analgesic efficacy of the two infusion regimens (see
below).
Postoperative pain scoring
The Echelle Douleur Inconfort Noveau (EDIN) pain
score instrument is a validated pain score for use in pre-
term infants (11) and represents standard of care in our
NICU. Assessment of pain was performed hourly and
additional assessments were performed as needed in
between the hourly recordings.
A pain score of 3–5 was set as the target range (min
score: 0; max score: 15). A score below the target zone
for six consecutive hours resulted in a reduction of the
morphine infusion rate by 2.5 lg�kg�1�h�1.
A pain score above the target range resulted in admin-
istration of rescue analgesia (see below). If not corrected
by a single dose of rescue analgesia, the morphine infu-
sion rate was increased by 2.5 lg�kg�1�h�1.
Rescue analgesia
In case of pain score >5, the infant received an intrave-
nous dose of fentanyl (1 lg�kg�1).
Signs of systemic local anesthetic toxicity
The nursing staff was specifically instructed to note any
signs of ventricular cardiac arrhythmia or focal/general-
ized seizures.
Wound healing
The wound was inspected daily, and signs of leakage
(presence of visible clear liquid under the transparent
dressing) and infection were noted. Normal wound heal-
ing was defined as a scar free from signs of infection or
inflammation at 10 days postoperatively.
Study design, statistics, and randomization
Study design
Based on our previous data showing a substantial and
clinically relevant morphine sparing effect of the wound
catheter technique (>50% reduction of postoperative
morphine administration) (9), it was not considered ethi-
cal to include a placebo group to the study design. For
rationale regarding the chosen intermittent infusion reg-
imens, please see Discussion section.
Power calculation
As the primary aim of the present study was to deter-
mine the 24-h plasma concentration profile of LB associ-
ated with two different intermittent infusion regimens,
no power calculation was performed with regard to the
primary aim of the study.
Statistical methods
Mann–Whitney U-test was used when calculating differ-
ences between the two groups in terms of plasma con-
centrations. Classified data from two independent
populations were compared by Fisher0s exact test.
Randomization procedure
The patients were randomized into two groups, BII and
DII. The randomization was performed in blocks of 10
patients. The randomization codes were derived from
computer-generated numbers and allocated using the
sealed opaque envelopes technique.
Blinding procedures
To allow proper blinding, the study randomization was
performed by the hospital pharmacy. The pharmacy
provided syringes labeled with the patient number and
in which order they were to be given with every second
syringe containing either LB or normal saline. Every
8 h, the syringes were then switched according to the
study protocol.
Results
In total, 18 preterm infants were enrolled and random-
ized: Group BII: n = 9 and group DII: n = 9. Two
patients were excluded from the postoperative analgesia
analysis: One patient from group DII was excluded due
to an intraoperative surgical rift of the aorta, subse-
quently resulting in an unusual and complicated postop-
erative course. One patient in the BII group was
excluded from the analgesia analysis due to a protocol
violation with regard to the initial postoperative mor-
phine infusion rate (Figure 3).
Levobupivacaine plasma concentrations
The total amount of LB administered during the first
24 h postoperatively was 1.963 mg�kg�1 in Group BII
and 0.664 mg�kg�1 in Group DII.
As expected, the two infusion regimens were associ-
ated with different plasma concentration profiles, with
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LB plasma levels being clearly higher in the BII
group during the 10–16 postoperative period as com-
pared to the DII group (Figure 2). However, during
the latter part of the observation period (19–24 h),
the plasma levels of LB between the two groups
appeared to converge.
The maximal plasma concentration of LB in the BII
group was 1.682 lgml1 as opposed to 0.549 lgml1
in the DII group. Median plasma concentrations of LB
at 24 h were 0.342 lgml1 and 0.106 lgml1 in group
BII and DII, respectively (P = 0.0653).
Postoperative pain scores
The median hourly EDIN pain score during the 24-h
observation period was 0 (range: 0–15) in Group BII
and 1 (range: 0–11) in Group DII (P = ns).
Need for rescue analgesia
Number of patients in need for rescue analgesia was
lower in the BII group (n = 2) compared to group DII
(n = 7) (P = 0.0406). The vast majority of the fentanyl
doses (n = 12) in group DII was given during the 8–16-
h postoperative period as opposed to only four doses
during the 0–8 h period.
Total morphine consumption
The median morphine consumption was 272 lgkg1
(range: 170–494 lgkg1)24 h1 in group BII and
278 lgkg1 (range: 240–360 lgkg1)24 h1 in group
DII (P = ns).
Changes in morphine infusion rate
In the BII group, six patients got their morphine infu-
sion rate reduced during the study period (0–24 h) as
opposed to only one patient in the DII group.
We could not see any clear connection between the
reduction in morphine infusion rate and LB administra-
tion though.
Signs of systemic local anesthetic toxicity
No signs or symptoms of systemic local anesthetic toxic-
ity were noted during the study.
Removal of the catheter
No signs of pain or discomfort were noted during the
removal procedure.
Wound healing
In eight patients, a minimal amount of leakage fluid was
detected under the transparent dressing. Signs of wound
infection and a positive culture for staphylococcus and
enterococcus were present in one patient on postopera-
tive day 15 (group BII; treated by regular wound care
and appropriate antibiotics). In all other patients
(n = 17), the wound had healed as expected at 10 days
postoperatively.
Discussion
The main finding of the present study was that both
studied intermittent infusion regimens of local anesthetic
through a wound catheter were associated with accept-
able plasma levels of levobupivacaine as well as produc-
ing relevant postoperative analgesia in preterm infants
undergoing surgical PDA repair.
Before discussing the study results, we would like to
draw the reader’s attention to some aspects associated
with our study design. First, from a toxicity point of
view, the assessment of the free plasma concentration
of LB may be more closely linked to systemic toxicity
than the total plasma concentration (12). However, the
performance of proper free fraction analysis requires a
considerable sampling volume for each individual sam-
ple (at least 3 ml of blood per sample), resulting in a
Figure 2 Plasma concentrations of levobupicacaine during infusion
periods 2 and 3. ●, Concentrations in Group BII; ○, Concentrations in
Group DII. During the infusion period 1 (0–8 h), patients in Group BII
were treated with levobupicacaine and patients in Group DII were
treated with saline. No sampling data were obtained during this per-
iod. During the infusion period 2 (8–16 h), patients in Group BII were
treated with saline and patients in Group DII were treated with levo-
bupicacaine. Sampling times: 10, 13, and 16 h. During the infusion
period 3 (16–24 h), patients in Group BII were treated with levobupic-
acaine and patients in Group DII were treated with saline. Sampling
times: 19, 22, and 24 h.
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278 lgkg1 (range: 240–360 lgkg1)24 h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DII (P = ns).
Changes in morphine infusion rate
In the BII group, six patients got their morphine infu-
sion rate reduced during the study period (0–24 h) as
opposed to only one patient in the DII group.
We could not see any clear connection between the
reduction in morphine infusion rate and LB administra-
tion though.
Signs of systemic local anesthetic toxicity
No signs or symptoms of systemic local anesthetic toxic-
ity were noted during the study.
Removal of the catheter
No signs of pain or discomfort were noted during the
removal procedure.
Wound healing
In eight patients, a minimal amount of leakage fluid was
detected under the transparent dressing. Signs of wound
infection and a positive culture for staphylococcus and
enterococcus were present in one patient on postopera-
tive day 15 (group BII; treated by regular wound care
and appropriate antibiotics). In all other patients
(n = 17), the wound had healed as expected at 10 days
postoperatively.
Discussion
The main finding of the present study was that both
studied intermittent infusion regimens of local anesthetic
through a wound catheter were associated with accept-
able plasma levels of levobupivacaine as well as produc-
ing relevant postoperative analgesia in preterm infants
undergoing surgical PDA repair.
Before discussing the study results, we would like to
draw the reader’s attention to some aspects associated
with our study design. First, from a toxicity point of
view, the assessment of the free plasma concentration
of LB may be more closely linked to systemic toxicity
than the total plasma concentration (12). However, the
performance of proper free fraction analysis requires a
considerable sampling volume for each individual sam-
ple (at least 3 ml of blood per sample), resulting in a
Figure 2 Plasma concentrations of levobupicacaine during infusion
periods 2 and 3. ●, Concentrations in Group BII; ○, Concentrations in
Group DII. During the infusion period 1 (0–8 h), patients in Group BII
were treated with levobupicacaine and patients in Group DII were
treated with saline. No sampling data were obtained during this per-
iod. During the infusion period 2 (8–16 h), patients in Group BII were
treated with saline and patients in Group DII were treated with levo-
bupicacaine. Sampling times: 10, 13, and 16 h. During the infusion
period 3 (16–24 h), patients in Group BII were treated with levobupic-
acaine and patients in Group DII were treated with saline. Sampling
times: 19, 22, and 24 h.
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clearly excessive total blood sampling volume per
patient. Therefore, to comply with the requirements of
the Ethics Committee, we decided to analyze only the
total plasma LB levels associated with the different
infusion regimens. Second, the choice of design of the
two administration regimens may need further clarifi-
cation. When starting with this new treatment, we
used an intermittent bolus injection technique (9).
Although effective, this regimen was often associated
with leakage through the wound itself or caused back-
flow alongside the catheter with substantial leakage
occurring from the catheter insertion site. Against this
background, continuous infusion appeared the better
option.
However, our pilot data from the use of continuous
infusion of LB were found to result in unwanted plasma
levels of LB after 24 h of continuous infusion (regularly
>1 lgml1). As a pragmatic compromise, we decided to
investigate two different administration protocols based
on intermittent infusion of LB. Third, the limited num-
ber of patients studied in each group admittedly does
limit the possibility to assess the secondary pharmacody-
namic end points.
Plasma concentrations of levobupivacaine
Albeit both infusion regimens being associated with
total plasma levels of LB that were below the proposed
toxic plasma concentration threshold for racemic bupi-
vacaine (2 lgml1) (12), the BII protocol, as expected,
resulted in higher plasma levels of LB compared to the
DII regimen (Figure 2). Furthermore, the BII regimen
was also associated with the presence of an outlier-indi-
vidual that peaked at a plasma concentration
(1.6 lgml1) not too far from the potentially toxic
threshold. In this context, one should also remember
that the toxic plasma level in preterm infants may be
considerably lower than the 2 lgml1 threshold that is
based on data from adults. One important circumstance
of this aspect is that the level of alpha-1 acid-glycopro-
tein (AAGP), the protein that is mainly responsible for
the pronounced protein-binding of local anesthetics,
most likely is considerable lower in preterm infants than
in adults. As an illustration of this issue, it has been
shown that the levels of AAGP in term neonates are
reduced by approximately 50% compared to adult val-
ues (13). Very few data regarding AAGP levels are cur-
rently available for preterm infants but one might
speculate that the AAGP levels could be even lower due
to the immaturity of the liver that is responsible for
AAGP synthesis. This may in turn result in higher free
plasma levels of LB than one normally would expect in
adults and hence the potentially toxic threshold for total
plasma levels may, thus, be substantially lower in pre-
term infants than in older subjects.
The choice of sampling times can of course be dis-
cussed. We decided, due to great limitations in terms of
amount of blood that could be obtained, that the chosen
time points were adequate for information of plasma
concentrations from a safety stand point.
Postoperative analgesia
The finding of low average EDIN pain assessment val-
ues during the postoperative observation period in
both treatment groups provides supportive evidence
for the potential of this multimodal postoperative anal-
gesia regimen, which combine a wound catheter infu-
sion of local anesthetics with a low–moderate
postoperative intravenous infusion of morphine. How-
Randomized (n = 18)
Allocated BII (n = 9)
Received Allocated Treatment
Pharmacokinetic analyzed (n = 9). One
patient excluded from pain analysis
due to protocol violation
Pharmacokinetic analyzed
(n = 9). One patient excluded from
pain analysis due to surgical
complication
Allocated DII (n = 9)
Received Allocated Treatment
Figure 3 Consort diagram.
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plasma levels of LB than one normally would expect in
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term infants than in older subjects.
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cussed. We decided, due to great limitations in terms of
amount of blood that could be obtained, that the chosen
time points were adequate for information of plasma
concentrations from a safety stand point.
Postoperative analgesia
The finding of low average EDIN pain assessment val-
ues during the postoperative observation period in
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for the potential of this multimodal postoperative anal-
gesia regimen, which combine a wound catheter infu-
sion of local anesthetics with a low–moderate
postoperative intravenous infusion of morphine. How-
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ever, the fact that the pain assessments on average
were lower than the target range in both groups does
suggest that even lower morphine infusion rates could
be used successfully.
Despite the observation of very similar pain assess-
ment values as well as almost identical median morphine
consumption during the first 24 postoperative hours in
both groups, a significantly higher number of patients in
Group DII did receive rescue fentanyl administration as
compared to patients in Group BII. This could obvi-
ously be interpreted as an advantage for the BII regi-
men. However, it should be noted that the need for
rescue fentanyl in the DII group was clustered to the
time period associated with the start of the LB infusion
in this patient group, thereby potentially indicating
insufficient onset of the analgesic effect of the local anes-
thetic infusion during this time window in Group DII. If
taken together the potential risk for occasional outlier-
patients when using the BII concept (Figure 2), our clin-
ical conclusion based on this study has been to routinely
use the DII model but to start the intermittent infusion
at 4 h after surgery instead of 8 h postoperatively.
A point of discussion when using wound infusions
of local anesthetics is of course the proper mechanism
of analgesia. Based on an extensive adult literature, it
appears reasonable to expect that a local effect is
responsible for the majority of the analgesic effect
associated with this technique. However, because
there is published evidence that intravenous infusions
of local anesthetics can produce clinically relevant
analgesia (14–16), it cannot be ruled out that systemic
absorption of the local anesthetic may in part con-
tribute to the overall analgesic effect resulting from
the use of this novel therapeutic approach.
Wound healing
A special concern associated with the use of a wound
catheter technique is whether it may negatively affect
the wound healing process. We find it reassuring that all
wounds healed as expected except one patient experienc-
ing a culture-verified superficial wound infection.
In conclusion, the use of both studied intermittent
infusion regimens in preterm infants undergoing surgical
ductus ligation was found to result in plasma levels of
levobupivacaine below what may be considered associ-
ated with a risk for systemic toxicity. Furthermore, both
regimens were associated with low postoperative pain
scores.
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ORIGINAL ARTICLE
Plasma levels of levobupivacaine during continuous
infusion via a wound catheter after major surgery in
newborn infants
An observational study
Joachim Krylborn, Marie E. Anell-Olofsson, Catarina Bitkover, Stefan Lundeberg, Marco Bartocci,
Carl-Olav Stiller and Bjorn A. Larsson
BACKGROUND Epidurals may be challenging in neonatal
patients due to technical difficulties relating to insertion and
the risk of local anaesthesia toxicity. The use of wound
catheters with an infusion of local anaesthetic has been
shown to be well tolerated in adults and older children.
There are few data concerning wound catheter techniques
in neonatal patients.
OBJECTIVES The primary aim of this study was to analyse
plasma levels of levobupivacaine associated with continuous
wound infiltration via a catheter following neonatal surgical
procedures. Secondary parameters, including the quality of
postoperative analgesia andwound healing, were also noted.
DESIGN A prospective, observational study.
SETTING Paediatric ICU at the Karolinska University Hos-
pital, Stockholm, Sweden, from March 2008 to December
2010.
PATIENTS Twenty newborn infants (median weight 3.48 kg)
scheduled for major abdominal or thoracic surgery were
included. Exclusion criteria were known or suspected hepa-
tic dysfunction. Before skin closure, a subcutaneous catheter
was inserted into the wound followed by a 0.5mg kg1 bolus
of levobupivacaine (0.125%, 0.4ml kg1) through the
catheter. A continuous infusion was started 20 to 30min
later at a rate of 0.2mg kg1 h1 (0.16ml kg1 h1).
MAIN OUTCOME MEASURES Plasma concentrations of
levobupivacaine (total and unbound) at 12, 24, 48 and 72h
postoperatively. Morphine consumption, pain scores and
wound healing were also analysed.
RESULTS Median concentrations of unbound and total
levobupivacaine at 72h were 0.018 and 1.305mgml1,
respectively. In 18 out of 20 infants [90%; 95% confidence
interval (CI) 68.3 to 98.8], the unbound plasma concen-
tration of levobupivacaine remained relatively stable and
below 0.05mgml1 throughout the 72h observation period.
Pain scores and morphine consumption levels were low. All
wounds except one healed within 10 days.
CONCLUSION The studied infusion regimen was associ-
ated with plasma levels of levobupivacaine well below
those associated with toxicity. Adequate wound healing,
low pain scores and a reduced need for opioids were also
noted.
Published online 1 August 2015
Introduction
In adult patients, the administration of continuous infu-
sions or intermittent boluses of local anaesthetics through
catheters placed into the surgical wound has become
increasingly popular due to its simplicity, efficacy and
safety.1,2 Positive paediatric pilot studies using continuous
wound catheter techniques have recently been published
with regard to their use in association with cardiac surgery,
iliac bone graft harvesting, orthopaedic and abdominal
surgery.3–5 However, to our knowledge, the use of wound
catheters in neonates has not been described.
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During the last few years, we have accumulated experi-
ence in the continuous administration of levobupivacaine
via wound catheters for postoperative analgesia following
various types of neonatal surgical procedures. There is a
need for data regarding the plasma levels of local anaes-
thetics associated with the use of such wound catheters in
order to safeguard against the risk of provoking local
anaesthetic systemic toxicity.
The primary aim of this study was to analyse the plasma
levels of levobupivacaine associated with continuous
wound infiltration following neonatal surgical procedures.
Secondary outcome parameters, including the quality of
postoperative analgesia, wound healing and time to
enteral feeding and endotracheal extubation were also
noted.
Materials and methods
Ethical approval for this study (Dnr: 2007/1462-31) was
provided by the ethical committee of Karolinska Insti-
tutet, Stockholm, Sweden (Chair Pierre Lafolie) on 10
March 2008 and the study was performed in accordance
with the declaration of Helsinki. After written parental
informed consent, 20 newborn infants (<1 month of age)
scheduled for major abdominal or thoracic surgery were
included in the study. Exclusion criteria were known or
suspected hepatic dysfunction.
A standardised anaesthetic technique was used. Preme-
dication was not used in any of the patients. Anaesthesia
was induced by atropine (10 to 20mg kg1), fentanyl (1 to
2mg kg1) and thiopentone (6 to 8mgkg1) or propofol (2
to 3mgkg1). Endotracheal intubation was facilitated by
succinylcholine (2 to 3mgkg1). Anaesthesia was then
maintained by sevoflurane (2 to 4%) in an oxygen/air
mixture. Additional fentanyl boluses (1 to 2mg kg1)
were administered at the discretion of the attending
anaesthetist. At the request of the surgeon, further
muscle relaxation was provided if required by the admin-
istration of a bolus of atracurium (0.5mgkg1). Following
closure of the muscle layers, the surgeon placed a multi-
orifice wound 19-gauge catheter (ON-Q PainBuster;
BBraun Melsungen AG, Melsungen, Germany) of length
2.5 or 6.5 cm according to the length of the surgical
incision, superficial to the muscle fascia under direct
vision. The subcutaneous tissue was subsequently closed
by single sutures and the skin was sutured by an intra-
cutaneous suturing technique. A transparent dressing was
also applied (Fig. 1). Immediately after skin closure, a
bolus dose of 0.5mgkg1 levobupivacaine (0.125%,
0.4ml kg1) was administered through the wound
catheter. After surgery, all children were transferred to
the paediatric ICU (PICU) for postoperative care. On
admission to the PICU, 20 to 30min after the initial
bolus, a continuous infusion of levobupivacaine 0.125%
was started at a rate of 0.2mgkg1 h1 (0.16ml kg1 h1)
using an infusion pump (Hospira GemStar; Hospira Inc.,
Lake Forest, Illinois, USA). The intended duration of the
postoperative levobupivacaine infusion was 72 h. The
catheters were removed after 72 h simply by gently pull-
ing them out after removal of the dressing.
The nurses were specifically instructed to monitor for
signs of local anaesthetic toxicity, namely any signs of
cardiac arrhythmia or local or generalised seizures. Exam-
ination by a paediatric anaesthetist was called upon if
needed. Data from the monitoring system were also
obtained for analysis.
All patients were treated according to an established
multimodal sedoanalgesic PICU protocol, which
included the supplementation of regional anaesthesia
by the use of intravenous (i.v.) paracetamol (15 to
20mgkg1 three to four doses per 24 h) and clonidine
(1mg kg1 three to four doses per 24 h or as a continuous
infusion 5 to 8mg kg1 24 h1). Opioids were given if
indicated, for example, due to high pain scores. Pain was
recorded every 6 h during the 72 h postoperative obser-
vation period using the validated Astrid Lindgrens Chil-
dren’s Hospital Pain Scale (ALPS) (0, no pain at all to 10,
worst pain imaginable).6 A pain score less than 3 is
considered acceptable, a score of 3 to 5 indicates the
need for intervention, often in form of nursing care, and a
score more than 5 almost always indicates the need for
treatment with analgesics. All patients were assessed and
treated individually according to pain and comfort. The
amount of postoperative opioid administration during the
observation period was retrieved from the PICU patient
data management system (CliniSoft database; CliniSoft
Corporation, Wesley Chapel, Florida, USA).
The wound was inspected at least once daily until post-
operative day 10 (perceived as the normal time for wound
healing to occur). The following items were specifically
noted: leakage; presence of erythema around the wound;
signs of infection; and presence of normal wound healing
at postoperative day 10.
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Fig. 1
Wound catheter with external dressing applied following thoracotomy.
(Reproduced with permission from the parents).
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Blood samples (1.5ml each) were taken from indwelling
venous or arterial catheters (depending on availability) at
12, 24, 48 and 72h postoperatively. The blood samples
were subsequently centrifuged (Centrifuge 5804R;
Eppendorf AG, Hamburg, Germany) at 3000 rpm for
10min. The plasma was then separated and stored at
�208C until final analysis. Separate blood samples for
the determination of alpha-1-acid glycoprotein (AAG)
were taken at induction of anaesthesia and again at 72h
postoperatively. Levobupivacaine analyses were per-
formed at the Department of Clinical Pharmacology at
the Karolinska University Hospital according to Good
Laboratory Practice (GULP). Alpha-1-acid glycoprotein
was quantified at the Clinical Chemistry Laboratory at
Karolinska University Hospital Solana. Total levobupiva-
caine concentration was measured with reversed phase
high-pressure liquid chromatography (HPLC) with
mass elective detection (API-ES positive ion), using the
Agilent 1100 series system (Agilent Technologies,
Waldbronn, Germany). The range for quantification was
1.2 to 10 000nmol l�1 and the limit of detection was
0.35 nmol l�1. The method has a measurement insecurity
of less than 5% and was calibrated for every analysis.
Separation of the plasma proteins was accomplished by
the use of a regular ultrafiltration system (Amicon centri-
fuge, Bedford, Massachusetts, USA). The unbound con-
centration of levobupivacaine was subsequently analysed
using the same method as described above. Alpha-1-acid
glycoprotein was analysed by rate nephelometry
(IMMAGE; Beckman Coulter Inc., Brea, California,
USA). The range for quantification was 0.35 to 108g l�1.
Enteral feeding was attempted if signs of bowel move-
ments were present (as determined by auscultation,
flatulence or defaecation) or if gastric aspirates were
visibly clear and of minimal volume. Enteral feeding
was deemed successful if it did not result in gastric
retention or vomiting. The time to establishment of
successful enteral feeding was noted.
As this was a purely observational study, no power
calculation was performed. On the basis of prior plasma
concentration studies,7 we aimed to recruit 20 neonates to
this study. Plasma concentration data are expressed as
median (range). Pain scores are presented as median
values. The 95% confidence intervals (CIs) were calcu-
lated as stated by Ott and Mendenhall.8
Results
Population demographics and the surgical diagnoses are
shown in (Tables 1 and 2) respectively. Individual patient
data for total plasma levobupivacaine concentrations are
shown in Fig. 2a. Total postoperative levobupivacaine
plasma concentrations were 0.80 (0.17 to 1.92), 1.52 (0.06
to 2.05), 1.37 (0.14 to 3.15) and 1.30 (0.08 to 2.68) mgml�1
at 12, 24, 48 and 72 h, respectively. In most infants, the
total concentration of levobupivacaine was found to
increase during the first 48 h, followed by a slight
decrease from 48 to 72 h. The maximum total levobupi-
vacaine plasma concentration noted in the study was
3.15mgml�1.
Individual patient data for unbound plasma levobupiva-
caine concentrations are shown in Fig. 2b. Unbound post-
operative levobupivacaine plasma concentrations were
0.014 (0.002 to 0.05), 0.026 (0 to 0.059), 0.027 (0 to
0.208) and 0.017 (0 to 0.084) mgml�1 at 12, 24, 48 and
72h, respectively. In 18 out of 20 infants (90%; 95%CI68.3
to 98.8), the unbound plasma concentration of levobupi-
vacaine remained relatively stable and less than
0.050mgml�1 over the entire 72h observation period.
The maximum unbound levobupivacaine plasma concen-
tration noted in the study was 0.210mgml�1 at 48h.
Individual patient data for AAG are shown in Fig. 3.
Alpha-1-acid glycoprotein levels increased in all but four
patients. The unbound fraction of levobupivacaine at
72 h was 1.48 (0.4 to 4.8)%. No correlation between
AAG at 72 h and the unbound fraction of levobupivacaine
was observed. No signs or symptoms of local anaesthetic
systemic toxicity were observed during the study period.
The ALPS scores were found to be low throughout the
entire 72 h observation period at 2, 1, 0 and 1 at 12, 24, 48
and 72 h, respectively. In three patients, no supplemental
opioid was administrated during the observation period.
In the remaining 17 patients, the total amount of opioid
given during the first 72 h ranged from 0 to 1.40mgkg�1.
In seven infants out of 20 (35%; 95% CI 15.4 to 59.3),
some limited erythema around the wound could be
observed during the infusion of levobupivacaine. Leak-
age either at the edges of the wound or at the catheter
insertion site was noted in five patients; in one of these
patients, the infusion was stopped slightly prematurely
(at 68 h) due to excessive leakage. In this patient, the 72 h
blood samples were obtained at 68 h. In 18 patients out of
20 (90%; 95% CI 68.3 to 98.8), the wound had healed in
the expected manner by postoperative day 10. One
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Table 1 Patient demographics
Sex (male/female) 14/6
Gestational age at birth (weeksþdays) 39þ6 (36þ4 to 41þ5)
Postnatal age at time of surgery (days) 4 (1 to 30)
Weight (kg) 3.48 (2.87 to 4.29)
Data are median (range) or number.
Table 2 Surgical diagnosis
Diagnosis Number
Colonic atresia 1
Congenital diaphragmatic hernia 5
Pulmonary cyst 3
Duodenal atresia 3
Duodenal stenosis 1
Malrotation of the intestine 1
Oesophageal atresia 5
Tracheoesophageal fistula 1
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concentration studies,7 we aimed to recruit 20 neonates to
this study. Plasma concentration data are expressed as
median (range). Pain scores are presented as median
values. The 95% confidence intervals (CIs) were calcu-
lated as stated by Ott and Mendenhall.8
Results
Population demographics and the surgical diagnoses are
shown in (Tables 1 and 2) respectively. Individual patient
data for total plasma levobupivacaine concentrations are
shown in Fig. 2a. Total postoperative levobupivacaine
plasma concentrations were 0.80 (0.17 to 1.92), 1.52 (0.06
to 2.05), 1.37 (0.14 to 3.15) and 1.30 (0.08 to 2.68) mgml�1
at 12, 24, 48 and 72 h, respectively. In most infants, the
total concentration of levobupivacaine was found to
increase during the first 48 h, followed by a slight
decrease from 48 to 72 h. The maximum total levobupi-
vacaine plasma concentration noted in the study was
3.15mgml�1.
Individual patient data for unbound plasma levobupiva-
caine concentrations are shown in Fig. 2b. Unbound post-
operative levobupivacaine plasma concentrations were
0.014 (0.002 to 0.05), 0.026 (0 to 0.059), 0.027 (0 to
0.208) and 0.017 (0 to 0.084) mgml�1 at 12, 24, 48 and
72h, respectively. In 18 out of 20 infants (90%; 95%CI68.3
to 98.8), the unbound plasma concentration of levobupi-
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0.050mgml�1 over the entire 72h observation period.
The maximum unbound levobupivacaine plasma concen-
tration noted in the study was 0.210mgml�1 at 48h.
Individual patient data for AAG are shown in Fig. 3.
Alpha-1-acid glycoprotein levels increased in all but four
patients. The unbound fraction of levobupivacaine at
72 h was 1.48 (0.4 to 4.8)%. No correlation between
AAG at 72 h and the unbound fraction of levobupivacaine
was observed. No signs or symptoms of local anaesthetic
systemic toxicity were observed during the study period.
The ALPS scores were found to be low throughout the
entire 72 h observation period at 2, 1, 0 and 1 at 12, 24, 48
and 72 h, respectively. In three patients, no supplemental
opioid was administrated during the observation period.
In the remaining 17 patients, the total amount of opioid
given during the first 72 h ranged from 0 to 1.40mgkg�1.
In seven infants out of 20 (35%; 95% CI 15.4 to 59.3),
some limited erythema around the wound could be
observed during the infusion of levobupivacaine. Leak-
age either at the edges of the wound or at the catheter
insertion site was noted in five patients; in one of these
patients, the infusion was stopped slightly prematurely
(at 68 h) due to excessive leakage. In this patient, the 72 h
blood samples were obtained at 68 h. In 18 patients out of
20 (90%; 95% CI 68.3 to 98.8), the wound had healed in
the expected manner by postoperative day 10. One
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Table 1 Patient demographics
Sex (male/female) 14/6
Gestational age at birth (weeksþdays) 39þ6 (36þ4 to 41þ5)
Postnatal age at time of surgery (days) 4 (1 to 30)
Weight (kg) 3.48 (2.87 to 4.29)
Data are median (range) or number.
Table 2 Surgical diagnosis
Diagnosis Number
Colonic atresia 1
Congenital diaphragmatic hernia 5
Pulmonary cyst 3
Duodenal atresia 3
Duodenal stenosis 1
Malrotation of the intestine 1
Oesophageal atresia 5
Tracheoesophageal fistula 1
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patient had a local reaction to a suture protruding through
the wound and one patient had a verified wound infection
with Staphylococcus aureus. The infected wound had
healed by postoperative day 10 with adequate treatment.
In four patients out of 20 (20%; 95%CI 5.7 to 43.7), enteral
feeding couldbe startedwithin 24h.Within 48h, 14 infants
out of 20 (70%; 95% CI 45.8 to 88.1) were able to tolerate
enteral feeding. Enteral feeding had successfully been
restarted postoperatively in all patients within 96h.
Within 24 h, 12 infants out of 20 (60%; 95% CI 36.0 to
80.9) had undergone successful tracheal extubation. The
cumulative tracheal extubation rate was 75% by 48 h and
95% by postoperative day 5. One patient suffered from
pulmonary hypertension and stayed on mechanical venti-
lation, including the use of inhaled nitric oxide, for an
extended period of time.
Discussion
The main findings of the present study were that con-
tinuous wound catheter infusion of levobupivacaine
according to our regimen resulted in plasma concen-
tration levels well below proposed toxic thresholds
and that no signs or symptoms of local anaesthetic
systemic toxicity were noted. Secondary outcomes
(postoperative pain scores, wound healing and time to
enteral feeding and endotracheal extubation) also
showed favourable outcomes.
Regional analgesia has become increasingly popular in
paediatric patients due to the excellent pain relief that it
provides. Recent studies have also indicated that the use
of epidural analgesia appears to be associated with accep-
table safety even in infants.9 However, case reports
referring to catastrophic outcomes following the
attempted use of epidural blockade in neonates have
been published10,11 and the safety of using the guidelines
for infusion rates of local anaesthetics in neonates for
longer than 48 h are being questioned.7 Thus, despite the
merits of epidural analgesia, there is a need for further
improvement, especially with regard to safety issues.12
Before commenting further on our results, we would like
to point out that, in our opinion and based on the wealth
of published data and longstanding track record, continu-
ous epidural analgesia remains the gold standard for
postoperative analgesia in neonates subjected to major
surgical interventions. Thus, further prospective, com-
parative randomised controlled trials are needed before
the place of continuous wound catheter techniques in
paediatric clinical care can be established.
The concept of a continuous infusion of local anaesthetic
into the surgical wound area relies on two separate mech-
anisms of spread of the local anaesthetic agent to even-
tually reach the peripheral nerve endings and small
peripheral nerve branches. First, vertical bulk transfer is
anticipated to take place between the various layers of the
surgical incision, thereby producing anaesthesia of both
the skin and subcutaneous tissue as well as the underlying
muscle layers. Second, local horizontal diffusion within
each tissue layer is assumed to result in a varying degree of
radial distribution to the area immediately adjacent to the
incision. These two mechanisms are dependent on both
the concentration of local anaesthetic agent and the
volume per hour that is infused through the catheter.
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concentrations of levobupivacaine during the study period. Median values are represented by the horizontal bar.
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patient had a local reaction to a suture protruding through
the wound and one patient had a verified wound infection
with Staphylococcus aureus. The infected wound had
healed by postoperative day 10 with adequate treatment.
In four patients out of 20 (20%; 95%CI 5.7 to 43.7), enteral
feeding couldbe startedwithin 24h.Within 48h, 14 infants
out of 20 (70%; 95% CI 45.8 to 88.1) were able to tolerate
enteral feeding. Enteral feeding had successfully been
restarted postoperatively in all patients within 96h.
Within 24 h, 12 infants out of 20 (60%; 95% CI 36.0 to
80.9) had undergone successful tracheal extubation. The
cumulative tracheal extubation rate was 75% by 48 h and
95% by postoperative day 5. One patient suffered from
pulmonary hypertension and stayed on mechanical venti-
lation, including the use of inhaled nitric oxide, for an
extended period of time.
Discussion
The main findings of the present study were that con-
tinuous wound catheter infusion of levobupivacaine
according to our regimen resulted in plasma concen-
tration levels well below proposed toxic thresholds
and that no signs or symptoms of local anaesthetic
systemic toxicity were noted. Secondary outcomes
(postoperative pain scores, wound healing and time to
enteral feeding and endotracheal extubation) also
showed favourable outcomes.
Regional analgesia has become increasingly popular in
paediatric patients due to the excellent pain relief that it
provides. Recent studies have also indicated that the use
of epidural analgesia appears to be associated with accep-
table safety even in infants.9 However, case reports
referring to catastrophic outcomes following the
attempted use of epidural blockade in neonates have
been published10,11 and the safety of using the guidelines
for infusion rates of local anaesthetics in neonates for
longer than 48 h are being questioned.7 Thus, despite the
merits of epidural analgesia, there is a need for further
improvement, especially with regard to safety issues.12
Before commenting further on our results, we would like
to point out that, in our opinion and based on the wealth
of published data and longstanding track record, continu-
ous epidural analgesia remains the gold standard for
postoperative analgesia in neonates subjected to major
surgical interventions. Thus, further prospective, com-
parative randomised controlled trials are needed before
the place of continuous wound catheter techniques in
paediatric clinical care can be established.
The concept of a continuous infusion of local anaesthetic
into the surgical wound area relies on two separate mech-
anisms of spread of the local anaesthetic agent to even-
tually reach the peripheral nerve endings and small
peripheral nerve branches. First, vertical bulk transfer is
anticipated to take place between the various layers of the
surgical incision, thereby producing anaesthesia of both
the skin and subcutaneous tissue as well as the underlying
muscle layers. Second, local horizontal diffusion within
each tissue layer is assumed to result in a varying degree of
radial distribution to the area immediately adjacent to the
incision. These two mechanisms are dependent on both
the concentration of local anaesthetic agent and the
volume per hour that is infused through the catheter.
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Considering that the surgical wound in adults on
occasions can involve both a considerable incisional
length and a substantial wound depth, it is slightly
surprising that wound catheter techniques can be suc-
cessfully employed (e.g. Pfannenstiel incisions in gynae-
cological and obstetric surgery).13 However, a number of
reviews and meta-analyses do show that wound catheter
techniques represent a useful therapeutic option for
postoperative analgesia in adults.14,15 In contrast, the size
of the surgical incision is substantially smaller in children,
which is especially true in the neonatal situation wherein
the incision length and tissue depth is minimal. Further-
more, the texture of the tissues in neonates is generally
more favourable for diffusion than adults. Thus, neonates
should on theoretical grounds provide almost ideal con-
ditions for wound catheter analgesia to be efficacious.
On the basis of the difficulties and risks associated with
the insertion of epidural catheters in very low-weight
babies (<1500 g) for a number of years, we have used a
wound catheter technique in preterm infants undergoing
surgical closure of patent ductus arterious.16 On the basis
of a greater than 50% reduction in postoperative mor-
phine administration in infants treated with wound
catheters as compared with no regional anaesthesia
(unpublished data), we decided to perform the current
study in neonates as a pilot for further prospective,
comparative, randomised clinical trials. A special focus
of the present study was to identify a well tolerated and
effective local anaesthetic infusion regimen in this popu-
lation that could be used in future clinical trials.
The dose and concentration of levobupivacaine used in
our study was based on our previous clinical experience
over several years. The dose and volume is also the same
as we have used in lumbar epidurals in similar patients.7
No specific data with regard to the plasma levels associ-
ated with early or manifestations of local anaesthetic
toxicity are currently available for levobupivacaine.
However, it is reasonable to expect that such values
should be somewhat higher than those for racemic
bupivacaine. Thus, if compared with the potentially
toxic plasma concentrations of racemic bupivacaine
(unbound bupivacaine 0.3mgml1, total bupivacaine
4mgml1),17,18 all our measured levobupivacaine con-
centrations fell within what is accepted as a reasonable
safety margin. In eight patients, we noted a tendency
towards higher total concentrations of levobupivacaine.
These patients showed no differences in terms of oper-
ation mode, postnatal age or preoperative medical status
compared with the rest of the study population. Despite
slowly rising total plasma concentrations during the
time period of 0 to 48 h (Fig. 2a), the unbound concen-
tration that is linked to potential toxicity remained
remarkably stable in the vast majority of babies over
the 72 h postoperative observation period (Fig. 2b). As
AAG generally has a high affinity for local anaesthetics,
the observation of stable unbound concentrations of
levobupivacaine can most likely be explained by the
increase in postoperative AAG levels (Fig. 3), which
represents an integral part of the acute phase reaction
that is triggered by surgery and the associated neuro-
endocrine surgical stress response.19 The patient who
had the highest unbound concentration of levobupiva-
caine at 48 h also had a high total concentration at the
same time. There was no correlation to low AAG levels
at 72 h. This patient underwent thoracotomy for repair
of oesophageal atresia and had no signs of hepatic or
renal impairment before or after surgery. The stable
concentrations of unbound levobupivacaine seen during
the 72 h postoperative observational period, together
with the absence of any signs indicative of local anaes-
thetic toxicity, appear to support the clinical safety of
the infusion regimen used in this study.
The combined use of our wound catheter regimen with a
standardised analgesic protocol was found to result in a
favourable pain score profile during the 72 h postopera-
tive observation period, indicating clinically satisfactory
analgesia. The observation that three patients did not
need any additional administration of opioids at all during
the observation period points to the analgesic potential of
the wound catheter technique. Compared with the stan-
dard continuous opioid (morphine) infusion rate
(20mg kg1 h1) used in neonates not receiving regional
anaesthesia in our centre, only one catheter appeared not
to be associated with any clinically relevant opioid-
sparing effect. The observations that the infants
could undergo tracheal extubation and resume enteral
feeding in line with what is normally seen with the use of
epidural analgesia in this age group appear to support the
postoperative efficacy of the wound catheter technique
used.
For obvious reasons, various wound-related parameters
are of special interest when wound catheter infusions are
used. In 18 patients (90%), normal wound healing was
observed. The observed reaction to a protruding suture is,
in our opinion, not related to the wound catheter tech-
nique per se but instead due to the surgical suturing
technique. Only one case of suboptimal wound healing
(culture verified infection) was noted, which eventually
healed without excessive scaring following local treat-
ment and adequate antibiotic therapy. The erythema that
could be observed around the wound during the infusion
of local anaesthetic in 33% of the neonates is most likely
due to local vasodilatation caused by levobupivacaine and
the erythema subsided soon after discontinuation of the
infusion in all cases. Excessive leakage of infused local
anaesthetic occurred in one patient and the infusion was
terminated slightly earlier than initially planned (68 vs.
72 h). On the basis of the experience gained from this
limited cohort, wound catheter infusions of levobupiva-
caine do not appear to interfere with the wound healing
process to any major extent.
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with the absence of any signs indicative of local anaes-
thetic toxicity, appear to support the clinical safety of
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tive observation period, indicating clinically satisfactory
analgesia. The observation that three patients did not
need any additional administration of opioids at all during
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epidural analgesia in this age group appear to support the
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used. In 18 patients (90%), normal wound healing was
observed. The observed reaction to a protruding suture is,
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nique per se but instead due to the surgical suturing
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This study has some limitations that need consideration.
First, due to the special circumstances associated with the
care of neonates, the blood samples were collected from
the best available intravascular catheter, which resulted
in blood samples being taken either from an arterial line
or a venous catheter. It is well known that arterial and
venous plasma concentrations differ in the immediate
phase following a bolus injection of local anaesthetic as
part of a single injection block technique.20 However, as
the first blood sample was taken 12 h after the start of the
bolus along with continuous infusion regimen, it is
reasonable to assume that arterial and venous blood
samples should have equilibrated with regard to levobu-
pivacaine concentration; this assumption is even more
probable for the samples collected during the later phase
of the observation period. Thus, we believe that this
minor imperfection in study design, necessitated by
clinical reality, will not have any major influence on
the final study results. Second, although sufficient to
allow a reasonable estimate of individual plasma concen-
tration profiles associated with our neonatal infusion
regimen, the sample size is too small to allow any far-
reaching conclusions with regard to the secondary
parameters investigated in the present study. Third, it
is possible that higher plasma concentrations of levobu-
pivacaine could have occurred in conjunction with the
administration of the bolus dose. A specific issue when
trying to interpret the postoperative pain assessments is
that all children, apart from the standardised infusion of
levobupivacaine, received varying amounts of multimo-
dal sedoanalgesia that was required in order to permit
mechanical ventilation and PICU care. Thus, the overall
estimation of postoperative analgesia associated with our
wound catheter regimen must be interpreted with a
certain degree of caution. However, the combined pic-
ture of the secondary parameters is, in our opinion,
indicative of our wound catheter regimen being associ-
ated with an acceptable degree of clinical efficacy.
In conclusion, total and unbound plasma concentrations of
levobupivacaine remained within acceptable safety limits
when using our wound catheter infusion regimen in neo-
nates undergoing neonatal surgery. Furthermore, our regi-
men was associated with low pain scores, apparently
normal postoperative recovery andwas not associatedwith
any adverse effects with regard to wound healing. The
results of the study do in our opinion merit the perform-
ance of an adequately sized, prospective randomised trial
comparing the wound catheter technique with continuous
epidural analgesia in the context of postoperative analgesia
after neonatal surgery.
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The administration of local anaesthetics (LAs) by epidural
or wound catheter infusion represents valid options to provide
good postoperative analgesia after major surgery in both term
and preterm newborn infants.1e5 However, excessive dosage,
unintentional intravascular administration, or rapid systemic
absorption of LAs may cause serious complications, such as
seizures and haemodynamic collapse.6e8 Relevant safety is-
sues need to be addressed before recommending the wide-
spread use of regional anaesthesia in these patient categories.
LAs have a high affinity for plasma proteinsmaking the free
fractionof key concern regardingpotential LA systemic toxicity
(LAST). Alpha-1-acid glycoprotein (AAGP), an acute-phase
protein, is mainly responsible for the plasma binding of LAs.9
Low concentrations of AAGP are associated with reduced
binding of LAs and result in higher free plasma concentrations
of LAs that, in turn, will increase the risk for LAST. It has been
shown that plasma concentrations of AAGP in newborns are
approximately half of adult levels.10 LAs also bind to albumin
and red blood cells.11 As albumin concentrations also are
reduced in newborn and especially preterm infants, it will
probably not provide any additional safety regarding LAST. The
high haematocrit of newborn infants is only of limited impor-
tance.12 To our knowledge, AAGP concentrationshavenot been
determined in the very preterm population; furthermore, the
effect on AAGP concentrations caused by mode of delivery
(vaginal delivery vs Caesarean section) remains unexplored.
This is useful knowledge to avoid LAST and make dosage sug-
gestion in these patient categories.
The aim of this prospective observational study was to
determine AAGP plasma concentrations in preterm and term
newborns, andwhether there was a correlation between AAGP
concentrations and gestational age, birth weight, gender, and
mode of delivery.
Methods
Study population
Ethical approval for this study (Dnr:2014/64-31/2) was provided
by the ethical committee of Karolinska Institutet, Stockholm,
Sweden on April 19, 2014. After written parental informed
consent, 70 newborn infants were included in the study.
Blood sampling and measurements
Immediately after delivery, 1 ml blood was sampled from
the umbilical artery attached to the placenta. The blood
was collected in micro-cuvettes (Microvette® 500 K2-
ethylenediaminetetraacetic acid (EDTA) 500 ml; Sarstedt AG
and Co., Nu¨mbrecht, Germany) and sent for further handling in
the hospital laboratory. In the laboratory (Karolinska University
Hospital, Huddinge, Sweden, accredited in accordance with the
International Standard ISO15189:2012), themicro-cuvetteswere
centrifuged at 20C for 10min using the Sigma 1e14K centrifuge
(LABEX Instrument AB, Osterode am Harz, Germany). Plasma
AAGP (orosomucoid) was analysed in EDTA plasma with an
immunoturbidimetric assay, cobas C system (Roche Di-
agnostics, Mannheim, Germany). The lower limit of quantifica-
tionwas 0.1 g litre1, defined as three standard deviations above
the lowest standard. The total coefficient of variation was 5%.
Investigated parameters
The AAGP concentrations were analysed in relation to gesta-
tional age, birth weight, gender, and mode of delivery (vaginal
delivery vs Caesarean section).
Statistical analyses
Median values and inter-quartile range (IQR) were used when
describing AAGP concentrations. KruskaleWallis test was used
to compare concentrations of AAGP between infants born with
different modes of delivery. To investigate the correlation be-
tween AAGP and gestational age, the Spearman correlation test
was used. Statistics were evaluated by GraphPad InStat 3.10
(GraphPad Software, La Jolla, California, USA).
Results
The patient characteristics of the included newborns are pre-
sented in Table 1. Six infants were excluded because of
Table 1 Patient characteristics. AAGP, alpha-1-acid glycoprotein; IQR, inter-quartile range.
Modes of delivery
Vaginal Elective Caesarean section Acute Caesarean section
Number of infants (n)z 31 26 13
Gender (male/female) 17/14 16/10 7/6
Gestational age at birth (days)
(median: minimumemaximum)
273 (191e295) 265 (222e279) 263 (190e293)
Body weight (g)
(median: minimumemaximum)
3363 (1734e4630) 3439 (1234e4790) 2873 (1058e4000)
AAGP concentration (g litre1)
(median: IQR)
0.189 (0.142e0.263) 0.110 (0.094e0.157) 0.182 (0.121e0.376)
Editor’s key points
 The acute-phase-protein alpha-1-acid glycoprotein
(AAGP) has a high affinity for amide local anaesthetics.
 Lower AAGP concentration is associated with reduced
binding of amide local anaesthetics, and may increase
the risk for local anaesthetic toxicity.
 Newborns have lower AAGP concentrations than
adults, and AAGP concentrations increase after 260
days of gestation.
 AAGP concentrations can also increase during stressful
situations, such as a normal vaginal delivery or
Caesarean section, and could therefore influence the
free concentration of local anaesthetics and the devel-
opment of local anaesthetic toxicity.
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missing values from the laboratory. The median plasma con-
centration of AAGP in cord blood was 0.158 g litre�1 (IQR
0.110e0.216).
Plasma concentrations of AAGP in relation to gender
or birth weight
The median plasma concentrations of AAGP were 0.148 g
litre�1 (IQR 0.110e0.240) and 0.160 g litre�1 (IQR 0.102e0.210) in
male and female newborns, respectively (P¼0.988). We found
no correlation between AAGP concentrations and birth weight
(r¼0.18; P¼0.162).
Plasma concentrations of AAGP in relation to mode of
delivery or gestational age
The median plasma concentrations of AAGP were 0.110 g
litre�1 (IQR 0.094e0.157) and 0.189 g litre�1 (IQR 0.142e0.263) in
newborn infants delivered by elective Caesarean section and
vaginally, respectively (P¼0.0003; Fig. 1). The median plasma
concentration of AAGP was 0.182 g litre�1 (IQR 0.121e0.376) in
the group delivered by acute Caesarean section. The concen-
tration of AAGP remained stable until 260 gestational days.
Thereafter, the AAGP concentrations augmented with
increasing gestational age (r¼0.50; P¼0.011; Fig. 2). AAGP con-
centrations were as high as 0.78 and 0.42 g litre�1 in two in-
fants born <220 days of gestation (delivered vaginally and by
acute Caesarean section, respectively). The third infant born
<220 days of gestation had an AAGP concentration of 0.14 and
was delivered vaginally.
Discussion
The acute-phase protein AAGP has a high affinity for amide
LAs and is a major determinant of free and potentially toxic
concentrations of LAs in plasma. Themain finding of our study
was that AAGP plasma concentrations in newborn infants are
low (approximately 20% of normal adult concentrations)13 and
appear stable at a low concentration during 260 days of
gestation. AAGP concentrations were significantly higher in
infants born by normal vaginal delivery compared with
elective Caesarean section. Among the participants in our
study, there were two infants born <220 gestational days who
had high concentrations of AAGP presumably as a response to
the stress of being born (one being born vaginally and the other
by acute Caesarean section). This may indicate that even very
preterm infants can increase their AAGP production in
response to stress.
Preterm and term newborn infants are occasionally sub-
jected to major surgery and need the best possible post-
operative analgesia. Morphine and other opioids are
frequently used, but their routine use has recently been
debated.14e16 The trend in adult postoperative care is moving
away from routine use of opioids for various reasons.17,18
Regional anaesthetic techniques are now used in children2
and can be used even in extremely preterm infants.19 How-
ever, unintentional overdosing, inadvertent intravascular
administration, or excessive absorption of LAs from the in-
jection site may cause serious side-effects (e.g. seizures and
haemodynamic collapse).6e8
In earlier studies, we have found acceptable plasma con-
centrations of LAs regarding the risk of LAST, combined with
the lack of observed side-effects both in preterm and term
newborn infants.19 Even so, there are still unresolved safety
issues especially in preterm infants. Defining the AAGP
plasma concentrations also in the preterm population is of
importance, as low concentrations will reduce plasma protein
binding, thereby increasing the free and potentially toxic
plasma concentration of LAs.
Plasma concentrations of AAGP in preterm and term
newborns
Previous studies have shown that AAGP plasma concentra-
tions in infants are lower than in adults, and that AAGP does
not reach adult values until 1 yr of age.10 Our results show that
AAGP concentrations appear to remain stable at a low level
until 260 days of gestational age when the levels start to rise
significantly. One interpretation of this finding is that the he-
patic production of AAGP is immature until about 260 days (36
gestational weeks) when the liver enzyme maturation results
in increased synthesis of the glycoprotein.
Increased plasma concentrations of AAGP are part of the
acute-phase-protein response that is triggered by various
Fig 1. Median alpha-1-acid glycoprotein (AAGP) concentrations
in newborn infants delivered by elective and acute Caesarean
section or vaginally.
Fig 2. Alpha-1-acid glycoprotein (AAGP) concentrations during
gestational age.
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modes of stress and constitutes one aspect of the innate im-
mune response. It is well known that vaginal delivery is
associated with a substantial endocrine stress response that is
considerably higher than what is observed in association with
elective Caesarean section.20 It has hitherto been unknown
whether the stress of vaginal delivery is substantial enough to
trigger an increased production of AAGP. In line with our
prediction, AAGP concentrations were significantly higher af-
ter normal vaginal and acute Caesarean delivery than after
elective Caesarean section. The number of infants in the age
range <260 days (27e36 gestational weeks) was too small to
allow for a separate post hoc analysis, but a similar pattern was
observed also in this patient category.
Study limitations
Despite the fact that all potential mothers gave consent during
the inclusion period, the actual number of preterm infants
(<37 gestational weeks) was numerically small (n¼14). This is,
of course, a limiting factor that precluded a proper subgroup
analysis of these subjects concerning the effect by mode of
delivery. To analyse the influence of the low levels of AAGP on
the in vitro free fraction of LAs would, of course, have provided
further data of interest. To determine plasma protein binding
properly would need a total plasma volume of approximately 5
ml. Because of high haemoglobin levels at birth, it is not
practically possible to harvest the necessary blood volume to
allow proper in vitro plasma binding determinations. In vitro
studies are also influenced by other various factors (e.g. pH
and temperature)12 that further complicate such studies.
Against this background, we decided to refrain from
attempting to do in vitro analyses of plasma protein binding. It
should be noted that eight of the AAGP concentration values in
the material were slightly below the lower limit of quantifi-
cation for the instrument used. Seven of these values were
immediately below the limit (0.077e0.099).
Implications for dosing of LAs in newborn infants
The generally adopted guidelines for safe administration of
LAs in children recommend a 40% reduction of the initial bolus
and a 50% reduction of the maintenance infusion in neonates
compared with older children.21
The variability in our material is substantial. This is mainly
caused by the increasing concentrations of AAGP after 260
days of gestational age. However, during the period 220e260
days, the concentrations are reasonably stable at around 0.15 g
litre�1. Thus, an increased awareness for LAST and a further
dose reduction (compared with the recommendations
mentioned previously) could be used in patients under the
gestational age of 260 days (36 weeks). Further reduction of the
dose does not appear to be needed down to 220 days (27 weeks)
according to our material.
Furthermore, when challenged with a neonatal surgical
patient, not only pre- and postnatal ages need to be taken into
consideration, but also the mode of delivery represents a fac-
tor in this context. Thus, slightly higher doses may be possible
to use in infants born by normal vaginal delivery and acute
Caesarean section than those born via elective Caesarean
section. Our results also imply that even preterm infants are
able to increase AAGP production in response to stressful
events, and thus, should be able to increase their AAGP levels
after surgery [e.g. surgical patent ductus arteriosus (PDA)
closure].
We are currently looking further into this issue in
extremely preterm infants undergoing surgical PDA closure.
Better understanding of AAGP plasma concentrations in pre-
term and term infants will hopefully help to allow the safe use
of continuous or intermittent boluses of LAs during the early
postoperative period in this specific patient category.
Furthermore, clearance of amide LAs is substantially lower in
preterm and term infants, which may increase the risk for
LAST further during continuous infusion.22,23 Thus, the use of
the ester LA, chloroprocaine, which is metabolised by plasma
esterases and largely independent of liver maturation, has
recently been suggested as a safer alternative.24
It is currently not possible to issue a more precise dosing
recommendation based on our findings, but hopefully more
studies in the field will lead to that. In conclusion, gestational
age and mode of delivery need to be taken into consideration
when determining the dosage of LAs in newborn infants.
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